Ralph H. Hruban

Q: What Schools Are Affiliated With Ralph H. Hruban

Ralph H. Hruban is affiliated with the following schools: University of Southern Denmark, University of New South Wales, Manipal Academy of Higher Education, University of Chicago, Baylor College of Medicine, Johns Hopkins University, University of Pittsburgh, Columbia University, Thomas Jefferson University, University of Bonn, Seoul National University

Ralph H. Hruban's AcademicInfluence.com Rankings

Ralph H. Hruban

Biology

#1255

World Rank

#2132

Historical Rank

Pathology

#13

World Rank

#30

Historical Rank

biology Degrees

Download Badge

Biology

Ralph H. Hruban's Degrees

Doctorate Medicine University of Chicago
PhD Pathology University of Chicago

Why Is Ralph H. Hruban Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ralph H. Hruban is professor of pathology and oncology at the Johns Hopkins School of Medicine. He is currently Director of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins, and Baxley Professor and Director of the Department of Pathology. He is a world expert on pancreatic cancer.

(See a Problem?)

Ralph H. Hruban's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (2008) (3758)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. (2015) (3718)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer (2009) (2855)
DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 (1996) (2441)
Genomic analyses identify molecular subtypes of pancreatic cancer (2016) (2343)
Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer (2010) (2299)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. (2003) (2209)
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. (2005) (2050)
Whole genomes redefine the mutational landscape of pancreatic cancer (2015) (1983)
A draft map of the human proteome (2014) (1901)
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. (1997) (1832)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis (2011) (1806)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes (2012) (1752)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 (2011) (1652)
Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) (1556)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors (2011) (1474)
Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators (2000) (1438)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer (2015) (1403)
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience (2006) (1373)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. (2000) (1246)
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma (1994) (1225)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (2013) (1148)
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. (1996) (1115)
Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions (2001) (1096)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. (2017) (1092)
An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms (2004) (1007)
Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients (1995) (972)
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. (2009) (939)
Gene expression profiles in normal and cancer cells. (1997) (901)
Altered Telomeres in Tumors with ATRX and DAXX Mutations (2011) (894)
Progression model for pancreatic cancer. (2000) (874)
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. (1996) (873)
Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience (2004) (870)
Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality (2002) (798)
Pancreatic cancer (1988) (797)
Recent progress in pancreatic cancer (2013) (790)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene (2009) (788)
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. (2000) (758)
Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. (1995) (757)
DPC4 gene in various tumor types. (1996) (745)
Tumor-suppressive pathways in pancreatic carcinoma. (1997) (729)
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. (1993) (714)
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development (2011) (711)
Pancreatic cancer (2011) (708)
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. (2003) (689)
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. (1997) (673)
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. (1996) (673)
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (2012) (661)
Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. (1995) (652)
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. (1997) (643)
The incidence of p53 mutations increases with progression of head and neck cancer. (1993) (640)
Prevalence of unsuspected pancreatic cysts on MDCT. (2008) (610)
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study (2005) (606)
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds (2004) (604)
Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. (2012) (592)
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. (2000) (591)
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. (2001) (567)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas (2013) (555)
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). (2001) (545)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. (2018) (538)
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways (2011) (535)
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas (2015) (529)
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. (2012) (528)
Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. (1991) (520)
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. (2006) (504)
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. (1994) (491)
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. (2003) (466)
Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*S (2006) (464)
p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. (1997) (459)
Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis (2001) (457)
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. (2002) (456)
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. (2002) (445)
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. (2004) (435)
Hypermethylation of multiple genes in pancreatic adenocarcinoma. (2000) (432)
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. (2003) (432)
Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas (2004) (430)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors (2012) (430)
ATM mutations in patients with hereditary pancreatic cancer. (2012) (427)
An In vivo Platform for Translational Drug Development in Pancreatic Cancer (2006) (427)
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. (1999) (424)
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity (2015) (417)
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. (1994) (415)
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. (2007) (407)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma (2011) (405)
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis (2010) (402)
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma (2011) (400)
Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray (2003) (390)
Genetic progression in the pancreatic ducts. (2000) (388)
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. (1994) (387)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. (2006) (385)
Allelotype of head and neck squamous cell carcinoma. (1994) (383)
Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. (1994) (381)
The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms (2015) (379)
Patterns of somatic structural variation in human cancer genomes (2020) (377)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation (2014) (377)
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. (2002) (368)
Echocardiographic findings in fulminant and acute myocarditis. (2000) (362)
Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer (2007) (354)
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients (2015) (354)
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. (1999) (350)
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. (2007) (347)
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. (1998) (345)
A combination of molecular markers and clinical features improve the classification of pancreatic cysts. (2015) (339)
Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. (2003) (337)
A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. (1990) (335)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma (2017) (332)
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. (2001) (332)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer (2009) (329)
Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases (1990) (329)
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. (2008) (328)
Pancreaticoduodenectomy (Whipple Resections) in Patients Without Malignancy: Are They All `Chronic Pancreatitis'? (2003) (326)
Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients (2004) (323)
Advances in counselling and surveillance of patients at risk for pancreatic cancer (2007) (318)
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. (2001) (317)
Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Increasingly Recognized Clinicopathologic Entity (2001) (317)
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma (2017) (316)
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. (2002) (312)
Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. (1998) (308)
Multifocal Neoplastic Precursor Lesions Associated With Lobular Atrophy of the Pancreas in Patients Having a Strong Family History of Pancreatic Cancer (2006) (308)
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. (2002) (308)
Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. (1998) (304)
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. (2001) (303)
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. (2000) (303)
Adenocarcinoma of the ampulla of Vater. A 28-year experience. (1997) (293)
Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. (1995) (288)
Homozygous deletion map at 18q21.1 in pancreatic cancer. (1996) (287)
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma (2012) (287)
Quality of life and outcomes after pancreaticoduodenectomy. (2000) (287)
SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions (2003) (285)
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer (2017) (281)
The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer (2007) (281)
Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types (2011) (278)
Epidemiology and risk factors (2002) (278)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas (2014) (276)
Periampullary adenocarcinoma: analysis of 5-year survivors. (1998) (276)
The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of Carcinogenesis (2002) (275)
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. (2017) (275)
MicroRNA‐21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 (2009) (273)
A Compendium of Potential Biomarkers of Pancreatic Cancer (2009) (272)
Follicular variant of papillary thyroid carcinoma. A clinicopathologic study (1994) (271)
MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls (2013) (269)
Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. (1998) (266)
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. (2016) (261)
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. (2000) (261)
Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers (2004) (260)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention (2020) (257)
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium (2019) (256)
Update on pancreatic intraepithelial neoplasia. (2008) (255)
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) (2015) (253)
Molecular genetics of pancreatic intraepithelial neoplasia. (2007) (252)
A Systematic Review of Solid-Pseudopapillary Neoplasms: Are These Rare Lesions? (2014) (252)
CT and MR imaging of benign hepatic and biliary tumors. (1999) (252)
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. (2002) (251)
Fanconi anemia gene mutations in young-onset pancreatic cancer. (2003) (249)
Focus on pancreas cancer. (2002) (247)
Update on familial pancreatic cancer. (2010) (247)
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. (2000) (244)
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. (2002) (244)
Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer (2010) (242)
Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p. (2001) (241)
Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. (2005) (241)
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. (2001) (240)
Familial pancreatic cancer: a review. (1996) (240)
Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer (2008) (238)
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. (2003) (238)
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. (1996) (236)
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. (1991) (236)
The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. (1999) (235)
Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. (1996) (234)
2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. (2014) (234)
Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. (2009) (234)
Overexpression of p53 protein in adenocarcinoma of the pancreas. (1994) (228)
BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. (2000) (228)
Allelotype of pancreatic adenocarcinoma. (1994) (228)
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinomad—part 3: Update on 5-year survival (2005) (227)
Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. (2001) (226)
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. (2019) (225)
Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. (1999) (223)
High resolution computed tomography of inflation-fixed lungs. Pathologic-radiologic correlation of centrilobular emphysema. (1987) (222)
Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. (2002) (221)
Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors (2012) (220)
Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors (2014) (218)
Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? (1996) (216)
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. (2018) (216)
BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study (2014) (215)
MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias (2011) (213)
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. (2013) (212)
Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. (2007) (210)
Long interspersed element-1 protein expression is a hallmark of many human cancers. (2014) (210)
Sites of Predilection in Recurrent Respiratory Papillomatosis (1993) (209)
Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer (2011) (208)
Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas (2010) (208)
DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. (2006) (207)
Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis (2003) (206)
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. (2013) (204)
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? (2014) (201)
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. (2003) (200)
Precursors to pancreatic cancer. (2007) (199)
Comprehensive proteomic analysis of human pancreatic juice. (2004) (199)
Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patients (1998) (198)
Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. (1998) (198)
Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
Castleman disease: the great mimic. (2011) (196)
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. (2003) (195)
Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. (2002) (194)
Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. (1990) (193)
Genetics of pancreatic cancer. From genes to families. (1998) (193)
Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas: A Clinicopathologic Analysis of 44 Cases (2014) (193)
Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. (2004) (193)
Resected Serous Cystic Neoplasms of the Pancreas: A Review of 158 Patients with Recommendations for Treatment (2007) (192)
Importance of Age of Onset in Pancreatic Cancer Kindreds (2010) (191)
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. (2016) (188)
PancPRO: risk assessment for individuals with a family history of pancreatic cancer. (2007) (188)
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. (2016) (186)
Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. (2002) (185)
Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients (2009) (185)
Tumors of the pancreas (2007) (183)
Cystadenomas of the pancreas: is enucleation an adequate operation? (1998) (182)
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. (2006) (178)
Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. (2002) (174)
Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms (2003) (171)
CT evaluation of amyloidosis: spectrum of disease. (1993) (168)
Clinicopathologic Analysis of Ampullary Neoplasms in 450 Patients: Implications for Surgical Strategy and Long-Term Prognosis (2010) (166)
Cystic precursors to invasive pancreatic cancer (2011) (166)
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. (2002) (165)
Tumor-infiltrating neutrophils in pancreatic neoplasia (2011) (164)
Human Proteinpedia enables sharing of human protein data (2008) (164)
In vivo Therapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor (2005) (161)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups (2014) (161)
Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. (1992) (161)
Periampullary and Pancreatic Incidentaloma: A Single Institution's Experience With an Increasingly Common Diagnosis (2006) (160)
EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. (2011) (160)
Hypermutation In Pancreatic Cancer. (2017) (160)
Mucinous cystic neoplasms of the pancreas. (2000) (159)
Should pancreaticoduodenectomy be performed in octogenarians? (1998) (159)
Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. (1994) (159)
Myocarditis and long-term survival in peripartum cardiomyopathy. (2000) (158)
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors (2012) (157)
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts (2012) (156)
Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas (2013) (156)
Pancreatic Intraepithelial Neoplasia (2004) (156)
RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma (2015) (155)
Molecular signatures of pancreatic cancer. (2011) (154)
Precursors to Invasive Pancreatic Cancer (2005) (154)
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers (2018) (154)
K‐ras oncogene activation in lung adenocarcinomas from former smokers evidence that K‐ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung (1993) (153)
Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate (2013) (151)
The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma (2014) (151)
Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. (1996) (151)
Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. (2000) (150)
Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. (1993) (149)
Should We Do EUS/FNA on Patients With Pancreatic Cysts? The Incremental Diagnostic Yield of EUS Over CT/MRI for Prediction of Cystic Neoplasms (2013) (149)
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. (2013) (149)
Precursors to invasive pancreatic cancer. (2012) (149)
miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts (2012) (149)
Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. (1994) (148)
Dpc4 Protein in Mucinous Cystic Neoplasms of the Pancreas: Frequent Loss of Expression in Invasive Carcinomas Suggests a Role in Genetic Progression (2000) (147)
Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia. (2009) (146)
A Single Institution's 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors: A Validation of Current Staging Systems and a New Prognostic Nomogram (2014) (145)
Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer (2008) (144)
Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. (2008) (143)
Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing (2012) (142)
Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma (2010) (142)
p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. (1995) (142)
ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma (2001) (140)
Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation (2014) (138)
Pancreatic Cancer Genetic Epidemiology Consortium (2006) (138)
Familial pancreatic cancer. (2009) (137)
DNA content and other factors associated with ten‐year survival after resection of pancreatic carcinoma (1998) (137)
Adenocarcinoma of the duodenum: factors influencing long-term survival (2007) (137)
Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? (2013) (136)
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms (2003) (136)
Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. (2001) (136)
Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. (2004) (135)
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. (2004) (135)
LigAmp for sensitive detection of single-nucleotide differences (2004) (134)
MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma. (2006) (134)
Evidence for a major gene influencing risk of pancreatic cancer (2002) (133)
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice (2019) (132)
Multi-detector row CT of pancreatic islet cell tumors. (2006) (132)
Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. (2002) (132)
Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification (2008) (131)
Functional defects in the fanconi anemia pathway in pancreatic cancer cells. (2004) (130)
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. (2006) (130)
Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. (1997) (130)
Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. (1999) (130)
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma. (2016) (129)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma (2016) (127)
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan (2019) (126)
Genetic mutations associated with cigarette smoking in pancreatic cancer. (2009) (126)
Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. (2008) (125)
Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: A prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors (2003) (125)
A white paper: the product of a pancreas cancer think tank. (2001) (124)
Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis. (1984) (124)
Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. (2003) (124)
A neural survival factor is a candidate oncogene in breast cancer (2003) (123)
K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium. (1998) (123)
Aberrant Methylation of the 5' CpG Island of TSLC1 Is Common in Pancreatic Ductal Adenocarcinoma and Is First Manifest in High-Grade PanINs (2002) (123)
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. (2001) (123)
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. (2003) (123)
Direct Correlation between Proliferative Activity and Dysplasia in Pancreatic Intraepithelial Neoplasia (PanIN): Additional Evidence for a Recently Proposed Model of Progression (2002) (122)
Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. (2002) (122)
Tumor Size and Location Correlate With Behavior of Pancreatic Serous Cystic Neoplasms (2011) (121)
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. (2005) (121)
New Markers of Pancreatic Cancer Identified Through Differential Gene Expression Analyses: Claudin 18 and Annexin A8 (2008) (120)
Spectrum of cystic tumors of the pancreas. (1992) (119)
17β-Estradiol Inhibits Apoptosis of Endothelial Cells (1997) (119)
Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival (2011) (118)
Almost All Infiltrating Colloid Carcinomas of the Pancreas and Periampullary Region Arise From In Situ Papillary Neoplasms: A Study of 39 Cases (2002) (118)
Clinicopathological Characteristics and Molecular Analyses of Multifocal Intraductal Papillary Mucinous Neoplasms of the Pancreas (2012) (118)
Diagnosis and Management of Cystic Lesions of the Pancreas (2011) (117)
Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. (1996) (117)
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. (2017) (117)
Mutant proteins as cancer-specific biomarkers (2011) (117)
Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs (2007) (117)
Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms (2016) (116)
Genome-wide aberrations in pancreatic adenocarcinoma. (2005) (116)
Diagnosing Pancreatic Cancer Using Methylation Specific PCR Analysis (2003) (116)
Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer? (2018) (116)
Pathology and Molecular Genetics of Pancreatic Neoplasms (2012) (115)
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma (2015) (115)
CpG island methylation profile of pancreatic intraepithelial neoplasia (2008) (115)
Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts (2001) (114)
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer. (2022) (114)
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (2018) (114)
Identifying markers for pancreatic cancer by gene expression analysis. (1998) (112)
Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. (2009) (112)
Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. (1987) (112)
Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. (1998) (112)
Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion (2005) (111)
Loss of Stk11/Lkb1 Expression in Pancreatic and Biliary Neoplasms (2003) (110)
Molecular pathology of pancreatic cancer. (2001) (110)
Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT? (2005) (109)
Lymphoplasmacytic Chronic Cholecystitis and Biliary Tract Disease in Patients With Lymphoplasmacytic Sclerosing Pancreatitis (2003) (109)
Identifying tumor origin using a gene expression-based classification map. (2003) (109)
Molecular pathogenesis of pancreatic cancer. (2006) (109)
Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? (2002) (109)
CT Findings in Bronchiolitis Obliterans Organizing Pneumonia (BOOP) with Radiographic, Clinical, and Histologic Correlation (1993) (108)
Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays (2004) (107)
Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest (1989) (107)
Amiodarone pulmonary toxicity: CT findings in symptomatic patients. (1990) (106)
Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma (2011) (106)
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. (1999) (106)
Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution (2015) (105)
Novel Markers of Pancreatic Adenocarcinoma in Fine-Needle Aspiration: Mesothelin and Prostate Stem Cell Antigen Labeling Increases Accuracy in Cytologically Borderline Cases (2003) (105)
Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas (2011) (105)
p16 Inactivation in Pancreatic Intraepithelial Neoplasias (PanINs) Arising in Patients With Chronic Pancreatitis (2003) (105)
K‐ras mutations in the duodenal fluid of patients with pancreatic carcinoma (1998) (105)
Preferential Expression of MUC6 in Oncocytic and Pancreatobiliary Types of Intraductal Papillary Neoplasms Highlights a Pyloropancreatic Pathway, Distinct From the Intestinal Pathway, in Pancreatic Carcinogenesis (2010) (104)
Groove pancreatitis: spectrum of imaging findings and radiology-pathology correlation. (2013) (103)
Pancreatic cancer. (2021) (102)
Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. (1992) (102)
Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment (2012) (101)
Proteogenomic characterization of pancreatic ductal adenocarcinoma (2021) (101)
Clear Cell Endocrine Pancreatic Tumor Mimicking Renal Cell Carcinoma: A Distinctive Neoplasm of Von Hippel–Lindau Disease (2001) (100)
PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma (2007) (100)
Predicting resectability of periampullary cancer with three-dimensional computed tomography (2004) (99)
Molecular pathogenesis of pancreatic cancer. (2006) (99)
Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking (1993) (98)
Pectus excavatum in a 112-year autopsy series: anatomic findings and the effect on survival. (2005) (98)
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy (2012) (98)
KRAS2 Mutations in Human Pancreatic Acinar-Ductal Metaplastic Lesions Are Limited to Those with PanIN: Implications for the Human Pancreatic Cancer Cell of Origin (2009) (98)
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. (2016) (96)
Peritransplant Injury to the Myocardium Associated with the Development of Accelerated Arteriosclerosis in Heart Transplant Recipients (1994) (96)
Surgical and molecular pathology of pancreatic neoplasms (2016) (95)
Histopathological Diagnosis of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary-Mucinous Neoplasms: Interobserver Agreement (2005) (94)
Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4 (2017) (94)
Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue. (2019) (94)
A multimodality test to guide the management of patients with a pancreatic cyst (2019) (94)
Eosinophilic Pancreatitis and Increased Eosinophils in the Pancreas (2003) (92)
Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. (2003) (92)
Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM) (2010) (92)
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (92)
Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. (1995) (92)
Cystic Pancreatic Neuroendocrine Tumors: A Clinicopathologic Study (2012) (92)
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas (2017) (91)
Pancreatic Cancer Cell DNA Content Correlates With Long‐term Survival After Pancreatoduodenectomy (1991) (90)
Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics. (2012) (90)
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study (2011) (90)
Small Cell Carcinoma of the Gallbladder: A Clinicopathologic, Immunohistochemical, and Molecular Pathology Study of 12 Cases (2001) (90)
Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer (2010) (89)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival (2016) (89)
Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. (2002) (89)
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo (2011) (88)
CT of the stomach: spectrum of disease. (1996) (88)
Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas (2014) (88)
One-month histologic response of transmyocardial laser channels with molecular intervention. (1996) (88)
Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. (2006) (88)
Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. (1994) (87)
Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The papanicolaou society of cytopathology guidelines for pancreatobiliary cytology (2014) (87)
Transcriptomic Biomarkers for the Accurate Diagnosis of Myocarditis (2011) (86)
RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. (1994) (86)
Wegener granulomatosis: CT features of parenchymal lung disease. (1991) (86)
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma (2020) (86)
K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. (1993) (85)
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium (2018) (85)
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer (2012) (85)
Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood (2019) (85)
Class III β‐tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia (2007) (84)
Surgical pathology dissection : an illustrated guide (1996) (84)
Human papillomavirus in sinonasal papillomas and squamous cell carcinoma (1992) (84)
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer (2019) (84)
The Genetics of FANCC and FANCG in Familial Pancreatic Cancer (2004) (84)
Molecular classification of neoplasms of the pancreas. (2009) (84)
Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer (2005) (84)
High resolution CT of the lung parenchyma with pathologic correlation. (1988) (83)
K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis. (2002) (83)
Pathology of incipient pancreatic cancer. (1999) (81)
Genetic and Epigenetic Alterations of Familial Pancreatic Cancers (2008) (81)
Precancer: a conceptual working definition -- results of a Consensus Conference. (2006) (81)
Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas (2008) (81)
Eosinophilia in chronic childhood sinusitis. (1995) (81)
Progress in cancer genetics: lessons from pancreatic cancer. (1999) (81)
Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways (2005) (81)
Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression (2004) (80)
A Phase I Clinical Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected with the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma. The Johns Hopkins Oncology Center, Baltimore, Maryland (1998) (79)
Intraductal papillary mucinous neoplasm. (2012) (77)
Resected periampullary adenocarcinoma: 5-year surVIVOrs and their 6 to 10-year follow-up (2006) (77)
An algorithmic approach to the diagnosis of pancreatic neoplasms. (2009) (76)
Abdominal lymphangiomas in adults (2006) (76)
Clinical importance of precursor lesions in the pancreas. (2007) (76)
IPMNs with co-occurring invasive cancers: neighbours but not always relatives (2018) (76)
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma (2009) (75)
Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis (2015) (75)
Precancerous neoplastic cells can move through the pancreatic ductal system (2018) (75)
Primitive Neuroectodermal Tumors of the Pancreas: A Report of Seven Cases of a Rare Neoplasm (2002) (75)
Multidrug resistance gene (MDR1) expression in human brain tumors. (1991) (74)
CT of splenosis: patterns and pitfalls. (2012) (74)
Brief report: molecular biology and the early detection of carcinoma of the bladder--the case of Hubert H. Humphrey. (1994) (74)
Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct. (2020) (74)
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases (2007) (73)
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. (2010) (73)
Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic Loss (2004) (72)
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. (2015) (72)
Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma (2005) (71)
Recent trends in the incidence and survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results analysis. (2020) (71)
Lessons from mammographic-histopathologic correlation of large-core needle breast biopsy. (1996) (71)
Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer (2007) (70)
Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke (2015) (70)
Carcinoid Tumors of the Extrahepatic Bile Ducts: A Study of Seven Cases (2000) (70)
Can we screen high‐risk individuals to detect early pancreatic carcinoma? (2000) (70)
The glucose transporter and blood‐brain barrier of human brain tumors (1990) (70)
Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. (2003) (69)
MAP2K4/MKK4 Expression in Pancreatic Cancer (2004) (69)
Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection (2008) (69)
Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. (1999) (69)
Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease. (1992) (69)
Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT. (2008) (69)
Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. (2016) (69)
Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships (2013) (68)
Pancreatic Mucinous Cystic Neoplasms with Sarcomatous Stroma: Molecular Evidence for Monoclonal Origin with Subsequent Divergence of the Epithelial and Sarcomatous Components (2000) (68)
Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: A potential new target for therapy (2005) (68)
Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes. (2020) (67)
Having Pancreatic Cancer with Tumoral Loss of ATM and Normal TP53 Protein Expression Is Associated with a Poorer Prognosis (2014) (66)
Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies. (2000) (66)
Why is pancreatic cancer so deadly? The pathologist's view (2019) (65)
Role of the DPC4 Tumor Suppressor Gene in Adenocarcinoma of the Ampulla of Vater: Analysis of 140 Cases (2003) (65)
Genomic Sequencing of DPC4 in the Analysis of Familial Pancreatic Carcinoma (1997) (65)
Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma (2018) (65)
p53 alterations in atypical alveolar hyperplasia of the human lung. (1998) (65)
Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer (2007) (65)
Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. (2013) (65)
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas (2011) (65)
Exomic Sequencing of Four Rare Central Nervous System Tumor Types (2013) (65)
Analysis of Anaphase Figures in Routine Histologic Sections Distinguishes Chromosomally Unstable from Chromosomally Stable Malignancies (2003) (65)
The two forms of bronchiolitis obliterans in heart-lung transplant recipients. (1991) (64)
Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived (2002) (64)
A neoplasm with pancreatic and hepatocellular differentiation presenting with subcutaneous fat necrosis. (1987) (63)
Progression of Gene Hypermethylation in Gallstone Disease Leading to Gallbladder Cancer (2003) (63)
Missense Mutations of MADH4 (2004) (63)
Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy (2017) (63)
Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas (2011) (63)
Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. (1999) (63)
Genetically Defined Subsets of Human Pancreatic Cancer Show Unique In Vitro Chemosensitivity (2012) (62)
Prevention of Pancreatic Cancer and Strategies for Management of Familial Pancreatic Cancer (2001) (61)
Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. (1992) (61)
Elevated Cancer Mortality in the Relatives of Patients with Pancreatic Cancer (2009) (61)
Intrapancreatic accessory spleen: CT appearance and differential diagnosis (2012) (61)
Molecular Characteristics of Pancreatic Ductal Adenocarcinoma (2011) (61)
Germline mutations in Japanese familial pancreatic cancer patients (2016) (60)
Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags (2004) (60)
Familial pancreatic cancer. (1999) (60)
Computed Tomography of Inflation‐fixed Lungs: The Beaded Septum Sign of Pulmonary Metastases (1989) (60)
Atheroembolism in cardiac surgery. (2003) (60)
Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells (2007) (59)
Pancreatic adenocarcinoma pathology: changing "landscape". (2015) (59)
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. (2001) (58)
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases. (2020) (58)
Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases (2015) (58)
Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics* (2014) (58)
The many faces of pancreatic serous cystadenoma: Radiologic and pathologic correlation. (2017) (58)
Overexpression of Lymphoid Enhancer-Binding Factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas (2014) (58)
Polymorphisms of SPINK1 N34S and CFTR in Patients with Sporadic and Familial Pancreatic Cancer (2003) (58)
Pdx1 Expression in Pancreatic Precursor Lesions and Neoplasms (2011) (57)
A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys (2012) (57)
Intraductal Papillary Mucinous Neoplasms Arise from Multiple Independent Clones, Each With Distinct Mutations. (2019) (57)
Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features. (2020) (57)
Pathological and molecular evaluation of pancreatic neoplasms. (2015) (56)
Familial pancreatic cancer. (2022) (56)
Evolutionary Origins of Recurrent Pancreatic Cancer (2019) (55)
Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns (2015) (55)
Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms (2007) (55)
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. (1998) (54)
Mixed epithelial and stromal tumor of the kidney: radiologic-pathologic correlation. (2010) (54)
Pancreatic cancer in mice and man: the Penn Workshop 2004. (2006) (54)
Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers (2017) (54)
Pyloric gland adenoma of the main pancreatic duct. (1999) (54)
Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. (2012) (54)
Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas. (2010) (53)
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. (2012) (53)
The deubiquitinase USP 9 X suppresses pancreatic ductal adenocarcinoma (2012) (53)
PIK3CA Mutations in Mucinous Cystic Neoplasms of the Pancreas (2014) (53)
Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer (2018) (52)
Pathology of cancer of the pancreas. (1998) (52)
Comparison of EUS-guided tissue acquisition using two different 19-gauge core biopsy needles: a multicenter, prospective, randomized, and blinded study (2014) (52)
Primary adrenal ganglioneuroma: CT findings in four patients. (1997) (52)
Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. (1994) (52)
Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer (2012) (52)
An Introduction to Pancreatic Adenocarcinoma Genetics, Pathology and Therapy (2002) (52)
Immunohistochemical and Genetic Analysis of Non–Small Cell and Small Cell Gallbladder Carcinoma and Their Precursor Lesions (2003) (51)
CT of inflation-fixed lungs: wedge-shaped density and vascular sign in the diagnosis of infarction. (1990) (51)
Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas (2016) (51)
Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. (2015) (51)
Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance. (2019) (51)
Chondroid Chordomas and Low-Grade Chondrosarcomas of the Craniospinal Axis: An Immunohistochemical Analysis of 17 Cases (1992) (51)
Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma (2006) (51)
Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence (2019) (51)
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. (2004) (50)
PAM4 enzyme immunoassay alone and in combination with CA 19‐9 for the detection of pancreatic adenocarcinoma (2013) (50)
Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience. (2019) (50)
Glutaric acidemia type II. Comparison of pathologic features in two infants. (1988) (50)
Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product. (1995) (50)
Young Patients Undergoing Resection of Pancreatic Cancer Fare Better than their Older Counterparts (2012) (49)
Pancreatic cancer. (2002) (49)
Familial pancreatic cancer: where are we in 2003? (2003) (49)
Tumor-suppressor genes in pancreatic cancer. (1998) (49)
Acinar cell carcinoma of the pancreas: computed tomography features—a study of 15 patients (2013) (49)
Novel germline p16INK4 allele (Asp145Cys) in a family with multiple pancreatic carcinomas (1998) (49)
Exome sequencing identifies frequent inactivating mutations in BAP 1 , ARID 1 A and PBRM 1 in intrahepatic cholangiocarcinomas (2014) (49)
Absence of germline BRCA1 mutations in familial pancreatic cancer patients (2009) (49)
Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver (2017) (49)
Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers (2000) (48)
EUS-guided tattooing before laparoscopic distal pancreatic resection (with video). (2010) (48)
Primary malignant neoplasms of the liver: detection with helical CT during arterial portography. (1994) (48)
Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs (2006) (48)
Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication (2020) (48)
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells (2017) (48)
Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer (2011) (47)
Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice. (2005) (47)
The Diagnosis and Surgical Treatment of Pancreatoblastoma in Adults: A Case Series and Review of the Literature (2013) (47)
Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. (2007) (47)
Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy. (2007) (47)
Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management. (2016) (47)
p53 gene mutations as markers of tumor spread in synchronous oral cancers. (1994) (47)
Hyaline Globules in Neuroendocrine and Solid-pseudopapillary Neoplasms of the Pancreas: A Clue to the Diagnosis (2011) (47)
Three-dimensional CT-volumetric reconstruction and display of the bronchial tree. (1990) (46)
The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting (2011) (46)
CT findings in cystic schwannoma of the pancreas. (1992) (46)
Chromosome abnormalities in pancreatic adenocarcinoma (1994) (46)
Surgical Pathology Dissection (1996) (46)
Allele-specific expression in the germline of patients with familial pancreatic cancer: An unbiased approach to cancer gene discovery (2008) (45)
The potential diagnostic use of K‐ras codon 12 and p53 alterations in brush cytology from the pancreatic head region (1998) (45)
GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as “Incipient IPMNs” (2014) (45)
Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations (2006) (45)
The autopsy: still important in cardiac surgery. (1997) (45)
Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: CT and pathology features. (2004) (44)
ACCELERATED GRAFT ARTERIOSCLEROSIS IN CARDIAC TRANSPLANTS: Complement Activation Promotes Progression of Lesions from Medium to Large Arteries1 (2001) (44)
Classification of Pancreatic Cysts in Computed Tomography Images Using a Random Forest and Convolutional Neural Network Ensemble (2017) (44)
Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. (1997) (44)
Sclerosing mesenteritis: depiction by multidetector CT and three-dimensional volume rendering. (2002) (43)
Diffuse esophageal leiomyomatosis in a patient with Alport syndrome: CT demonstration. (1991) (42)
Emerging molecular biology of pancreatic cancer. (2008) (42)
Molecular Biology and the Diagnosis and Treatment of Adenocarcinoma of the Pancreas (1996) (42)
Resected Adenocarcinoma of the Pancreas - 616 Patients (2000) (42)
Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate (2015) (42)
Institutional Experience With Solid Pseudopapillary Neoplasms: Focus on Computed Tomography, Magnetic Resonance Imaging, Conventional Ultrasound, Endoscopic Ultrasound, and Predictors of Aggressive Histology (2013) (42)
Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis (1999) (42)
Inducible Nitric Oxide Synthase Inhibition of Weibel-Palade Body Release in Cardiac Transplant Rejection (2001) (42)
Absence of Deleterious Palladin Mutations in Patients with Familial Pancreatic Cancer (2009) (42)
Copy-number variants in patients with a strong family history of pancreatic cancer (2007) (42)
Revisiting the tumorigenesis timeline with a data-driven generative model (2019) (42)
Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation. (2019) (42)
SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients (2008) (41)
Serum concentrations of cardiac troponin I in sudden death: a pilot study. (1998) (41)
Genome-Wide Somatic Copy Number Alterations in Low-Grade PanINs and IPMNs from Individuals with a Family History of Pancreatic Cancer (2012) (41)
Long survival with giant cell myocarditis. (1993) (41)
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. (2000) (41)
Resection of Isolated Renal Cell Carcinoma Metastases of the Pancreas: Outcomes from the Johns Hopkins Hospital (2014) (41)
Perforin expression localizing cytotoxic lymphocytes in the intimas of coronary arteries with transplant-related accelerated arteriosclerosis. (1993) (41)
Acinar Cell Cystadenoma of the Pancreas: A Benign Neoplasm or Non-Neoplastic Ballooning of Acinar and Ductal Epithelium? (2013) (41)
Sex differences in oncogenic mutational processes (2019) (41)
Molecular Characterization of Pancreatic Neoplasms (2008) (41)
Alterations of the p53 tumor‐suppressor gene and K‐ ras oncogene in perihilar cholangiocarcinomas from a high‐incidence area (1998) (40)
Single‐cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions (2019) (40)
Myocarditis associated with doxorubicin cardiotoxicity. (1993) (40)
Genetics of pancreatic neuroendocrine tumors: implications for the clinic (2015) (40)
Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors (2017) (40)
Adult Pancreatic Hemangioma: Case Report and Literature Review (2009) (40)
Complement as a mediator of vascular inflammation and activation in allografts. (2000) (40)
Chronic active myocarditis following acute Bartonella henselae infection (cat scratch disease). (2001) (40)
Massive retroperitoneal angiomyolipoma. A lesion that may be confused with well-differentiated liposarcoma. (1989) (40)
Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production? (2010) (39)
Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients. (1997) (39)
Solid-pseudopapillary neoplasm of the pancreas: spectrum of findings on multidetector CT. (2011) (39)
GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. (2012) (39)
Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas (2016) (39)
Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. (2011) (39)
CT Detection of Symptomatic and Asymptomatic Meckel Diverticulum. (2015) (39)
Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgery (2013) (39)
Detection of Early-Stage Pancreatic Adenocarcinoma (2010) (39)
Terminal Complement Components Mediate Release of von Willebrand Factor and Adhesion of Platelets in Arteries of Allografts (2005) (39)
Genomic characterization of malignant progression in neoplastic pancreatic cysts (2020) (39)
Familial and sporadic pancreatic cancer share the same molecular pathogenesis (2015) (39)
The Effect of a Frequently Asked Questions Module on a Pancreatic Cancer Web Site Patient/Family Chat Room (2005) (38)
Role of a Multidisciplinary Clinic in the Management of Patients with Pancreatic Cysts: A Single-Center Cohort Study (2014) (38)
Beyond renal cell carcinoma: rare and unusual renal masses (2012) (38)
Widespread Activation of the DNA Damage Response in Human Pancreatic Intraepithelial Neoplasia (2009) (38)
Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy (2017) (38)
Pancreatic Cancer Database (2014) (38)
Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. (2001) (38)
Assessment of “Gene–Environment” Interaction in Cases of Familial and Sporadic Pancreatic Cancer (2009) (38)
Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. (2007) (37)
Carcinoma of the body and tail of the pancreas. (1992) (37)
Assessing aneuploidy with repetitive element sequencing (2019) (37)
Real-time detection of mesothelin in pancreatic cancer cell line supernatant using an acoustic wave immunosensor. (2006) (37)
Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. (1987) (37)
Vascular Invasion in Infiltrating Ductal Adenocarcinoma of the Pancreas Can Mimic Pancreatic Intraepithelial Neoplasia: A Histopathologic Study of 209 Cases (2012) (37)
A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer. (2017) (36)
Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias (2010) (36)
Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases (2016) (36)
Prognosis of Minimally Invasive Carcinoma Arising in Mucinous Cystic Neoplasms of the Pancreas (2013) (36)
Gene expression profiling identifies markers of ampullary adenocarcinoma (2004) (36)
Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. (2019) (36)
Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (36)
A new mouse model of pancreatic cancer: PTEN gets its Akt together. (2005) (35)
Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: fifty patients. (1997) (35)
Spiritual issues of family members in a pancreatic cancer chat room. (2006) (35)
Stromal responses to carcinomas of the pancreas: Juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype (2005) (35)
Radiolabeled Anti-Claudin 4 and Anti-Prostate Stem Cell Antigen: Initial Imaging in Experimental Models of Pancreatic Cancer (2007) (35)
Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines (2014) (35)
Identification and analysis of precursors to invasive pancreatic cancer. (2005) (35)
Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. (2013) (35)
Dual-phase CT findings of groove pancreatitis. (2014) (35)
Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases. (2014) (34)
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system (2016) (34)
Surgical management of giant Brunner's gland hamartoma: case report and literature review (2009) (34)
Immunohistochemical expression of CD68 antigen in human peripheral blood T cells. (1994) (34)
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts (2017) (34)
Three-dimensional reconstruction of the human body. (1988) (34)
Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer (2019) (34)
Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs) (2018) (34)
Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection. (2001) (34)
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis. (2017) (34)
Large Cystic Pancreatic Neoplasms: Pathology, Resectability, and Outcome (1999) (34)
Fine‐needle aspiration of intrapancreatic accessory spleen: Cytomorphologic features and differential diagnosis (2012) (34)
Helicobacter pylori gastritis mimicking gastric carcinoma at CT evaluation. (1991) (34)
Abnormal air-filled spaces in the lung. (1993) (34)
The Quilty lesion enigma: Focal apoptosis/necrosis and lymphocyte subsets in human cardiac allografts (1998) (33)
Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion (2019) (33)
Mesothelin-specific CD 8 T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients (2004) (33)
17beta-estradiol inhibits apoptosis of endothelial cells. (1997) (33)
Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. (1988) (32)
Focal Fatty Infiltration in the Head of the Pancreas: Evaluation With Multidetector Computed Tomography With Multiplanar Reformation Imaging (2009) (32)
Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas (2017) (32)
Intestinal type adenocarcinoma: a previously unrecognized histologic variant of ductal carcinoma of the pancreas. (2007) (32)
Assessment of celecoxib pharmacodynamics in pancreatic cancer (2006) (32)
The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. (1997) (31)
Peripancreatic Paraganglioma: A Potential Diagnostic Challenge in Cytopathology and Surgical Pathology (2011) (30)
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. (2016) (30)
Sclerosing angiomatoid nodular transformation of the spleen (SANT): multimodality imaging appearance of five cases with radiology–pathology correlation (2013) (30)
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. (2013) (30)
Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: Case Report with Differential Diagnosis (2014) (30)
Expression and prognostic significance of 14-3-3 sigma and ERM family protein expression in periampullary neoplasms (2005) (30)
In situ characterization of the 3D microanatomy of the pancreas and pancreatic cancer at single cell resolution (2020) (30)
Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia. (2018) (30)
CT of gastric leiomyosarcoma: patterns of involvement. (1999) (30)
The great mimickers: Castleman disease. (2014) (29)
Human Correlates of Provocative Questions in Pancreatic Pathology (2012) (29)
Pulmonary disease associated with pleural "asbestos" plaques. (1989) (29)
Reexploration for periampullary carcinoma: Resectability, perioperative results, pathology, and long-term outcome (1999) (29)
Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas. (2017) (29)
Intimate association of eosinophils to collagen bundles in eosinophilic myocarditis and ranitidine-induced hypersensitivity myocarditis. (1995) (29)
Hepatic leiomyosarcomas: CT features with pathologic correlation. (1995) (29)
Diffuse Lymphoplasmacytic Chronic Cholecystitis Is Highly Specific for Extrahepatic Biliary Tract Disease but Does Not Distinguish Between Primary and Secondary Sclerosing Cholangiopathy (2003) (29)
CT of primary colonic lymphoma. (1994) (29)
Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology. (2018) (29)
Guidelines on the histopathology of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, (2020) (28)
A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas (2007) (28)
Pancreatic metastases from renal cell carcinoma in von Hippel-Lindau disease. (1997) (28)
Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. (1989) (28)
A simple new model of physiologically working heterotopic rat heart transplantation provides hemodynamic performance equivalent to that of an orthotopic heart. (1999) (28)
Abdominal schwannomas: review of imaging findings and pathology (2017) (28)
Linkage analysis of chromosome 4 in families with familial pancreatic cancer (2007) (28)
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects. (2001) (27)
Adjuvant Chemoradiation Therapy for Adenocarcinoma of the Distal Pancreas (2010) (27)
Adenocarcinoma of the pancreas. (2014) (27)
Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation. (2012) (27)
Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy (2018) (27)
Pancreatic Neuroendocrine Tumors: Update on the New World Health Organization Classification (2017) (27)
Acinar Cell Carcinoma of the Pancreas: Clinical and Cytomorphologic Characteristics (2013) (27)
Localization of the human cytomegalovirus 2.7-kb major early beta-gene transcripts by RNA in situ hybridization in permissive and nonpermissive infections. (1992) (27)
Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice (2013) (27)
Ultrastructural evidence of cell-mediated endothelial cell injury in cardiac transplant-related accelerated arteriosclerosis. (1993) (26)
Fine-needle aspiration cytology of monomorphic adenomas. (1988) (26)
Protection of the Internal Mammary Artery Pedicle with Polytetrafluoroethylene Membrane (1993) (26)
Molecular genetics and related developments in pancreatic cancer. (1999) (26)
Pancreaticoduodenectomy for selected pancreatic endocrine tumors. (1993) (26)
Surgical Resection of Malignant Melanoma Metastatic to the Pancreas: Case Series and Review of Literature (2012) (26)
PREVENTION OF SYNGENEIC GRAFT‐VERSUS‐HOST DISEASE BY RECOVERY OF THYMIC MICROENVIRONMENT AFTER CYCLOSPORINE (1991) (26)
Parosteal ossifying lipoma: CT and MR findings. (1993) (26)
Genetics of the FANCA gene in familial pancreatic cancer (2004) (26)
Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT. (2013) (26)
High‐resolution deletion mapping of chromosome arm 1p in pancreatic cancer identifies a major consensus region at 1p35 (1999) (25)
Cholecystectomy, liver resection, and pyloruspreserving pancreaticoduodenectomy for gallbladder cancer: Report of five cases (2002) (25)
Colloid cysts of the third ventricle: immunohistochemical evidence for nonneuroepithelial differentiation. (1992) (25)
Managing pancreatic cysts: less is more? (2015) (25)
Microcystic Serous Cystadenoma of the Pancreas With Subtotal Cystic Degeneration: Another Neoplastic Mimic of Pancreatic Pseudocyst (2012) (25)
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study (2016) (25)
Progressive hemochromatotic cardiomyopathy despite reversal of iron deposition after liver transplantation. (1993) (24)
Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome. (1998) (24)
CT‐Pathology Correlation of Amiodarone Lung (1990) (24)
A histomorphologic comparison of familial and sporadic pancreatic cancers. (2015) (24)
Correction: International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (Gut (2013) 62, (339-347)) (2014) (24)
Congenital bronchopulmonary foregut malformations. Intralobar and extralobar pulmonary sequestrations communicating with the foregut. (1989) (24)
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. (1996) (24)
Tropical pyomyositis: imaging findings and a review of the literature (1996) (24)
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning. (2012) (24)
Depletion of bronchus-associated lymphoid tissue associated with lung allograft rejection. (1988) (24)
Diseases of the chest in AIDS: CT diagnosis. (1989) (23)
Sclerosing Mesenteritis Involving the Pancreas: A Mimicker of Pancreatic Cancer (2010) (23)
Efficacy of Dimethylaminoparthenolide and Sulindac in Combination With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer (2013) (23)
Resected adenocarcinoma of the pancreas - 616 patients: Results, outcome and prognostic indicators (2000) (23)
Perforin Expression in Endometrium During the Menstrual Cycle (1995) (23)
Recommendations for the reporting of pancreatic specimens containing malignant tumors. Association of Directors of Anatomic and Surgical Pathology. (1999) (23)
Loss of Expression of Dpc 4 in Pancreatic Intraepithelial Neoplasia : Evidence That DPC 4 Inactivation Occurs Late in Neoplastic Progression 1 (2000) (22)
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma (2018) (22)
Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. (2015) (22)
Antithymocyte globulin is associated with complement deposition in cardiac transplant biopsies. (2004) (22)
Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms (2020) (22)
Pleural plaques do not predict asbestosis: high-resolution computed tomography and pathology study. (1991) (22)
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy (2020) (22)
Reporting precursors to invasive pancreatic cancer: Pancreatic intraepithelial neoplasia, intraductal neoplasms and mucinous cystic neoplasm (2012) (22)
Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report (2016) (22)
Establishment and Characterization of a New Cell Line, A99, From a Primary Small Cell Carcinoma of the Pancreas (2011) (21)
Metastatic disease to the pancreas: pathologic spectrum and CT patterns (2013) (21)
Neoplasms of the Neuroendocrine Pancreas: Introduction (2017) (21)
Thalidomide as replacement for steroids in immunosuppression after lung transplantation. (1995) (21)
Genomic Landscapes of Pancreatic Neoplasia (2015) (21)
Uniform long-term gene expression using adeno-associated virus (AAV) by ex vivo recirculation in rat-cardiac isografts. (2002) (21)
Intrahepatic, extramedullary hematopoiesis mimicking hemangioma on technetium-99m red blood cell SPECT examination. (1995) (21)
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma. (2013) (21)
Resectable pancreatic small cell carcinoma (2011) (21)
Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer (2012) (21)
Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM). (2008) (21)
Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts (2016) (21)
Cytomegalovirus nucleic acids in allografted hearts. (1990) (21)
Severe lymphocytic endothelialitis associated with coronary artery spasm in a heart transplant recipient. (1992) (20)
Duodenal diverticulum mimicking a cystic pancreatic neoplasm. (2005) (20)
Surveillance for pancreatic cancer in high‐risk individuals (2017) (20)
Mist 1-KrasG 12 D KnockIn Mice Develop Mixed Differentiation Metastatic Exocrine Pancreatic Carcinoma and Hepatocellular Carcinoma (2005) (20)
Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. (2021) (20)
Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation (2018) (20)
What is the Significance of Indeterminate Pulmonary Nodules in Patients Undergoing Resection for Pancreatic Adenocarcinoma? (2015) (20)
Pancreatic surgery for tumors in children and adolescents (2016) (20)
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System (2021) (20)
Loss of heterozygosity or intragenic mutation, which comes first? (2001) (20)
Fine Needle Aspirate of Autoimmune Pancreatitis (Lymphoplasmacytic Sclerosing Pancreatitis): Cytomorphologic Characteristics and Clinical Correlates (2012) (20)
Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer (2017) (20)
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer (2016) (19)
Multiscale label-free volumetric holographic histopathology of thick-tissue slides with subcellular resolution (2020) (19)
Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series. (2017) (19)
Rosai–Dorfman Disease (Sinus Histiocytosis with Massive Lymphadenopathy) of the Pancreas: Third Reported Occurrence (2012) (19)
Arterial Delivery of Genetically Labelled Skeletal Myoblasts to the Murine Heart: Long-Term Survival and Phenotypic Modification of Implanted Myoblasts (1996) (19)
Hyperplastic Luschka Ducts: A Mimic of Adenocarcinoma in the Gallbladder Fossa (2011) (19)
A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma (1993) (19)
Genomic FHIT analysis in RER+ and RER− adenocarcinomas of the pancreas (2000) (18)
Inflation-fixed lungs: pathologic-radiologic (CT) correlation of lung transplantation. (1990) (18)
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients with Pancreatic Cancer. (2020) (18)
Coagulation markers predicting cardiac transplant rejection. (2001) (18)
Spatial model predicts dispersal and cell turnover cause reduced intra-tumor heterogeneity (2015) (18)
Solid-Pseudopapillary Neoplasm of the Pancreas: Cytomorphologic Findings and Literature Review (2014) (18)
Acute pulmonary hemorrhage. CT evaluation. (1993) (18)
Hemorrhage from gastric mucosal tears complicating cardiopulmonary resuscitation. (1984) (18)
Autoimmune-mediated vasculopathy. (2001) (18)
Autoimmune Pancreatitis Accompanied by Cholecystitis, Periaortitis and Pseudotumors of the Liver (2008) (18)
Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistochemical study. (2005) (17)
Serum miR-1290 as a Marker of Pancreatic Cancer—Response (2013) (17)
Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma. (2005) (17)
Nuclear morphometry for prediction of metastatic potential in early squamous cell carcinoma of the floor of the mouth. (1992) (17)
Fatal fat embolism syndrome after numerous vertebral body compression fractures in a lung transplant recipient. (1994) (17)
Advancements in pancreatic neuroendocrine tumors (2013) (17)
Hypercalcemia and pancreatic endocrine neoplasia with elevated PTH-rP: Report of two new cases and subject review (2005) (17)
Characterization of Pancreatic Serous Cystadenoma on Dual-Phase Multidetector Computed Tomography (2014) (17)
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) (17)
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go (2020) (17)
Whole exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 (2018) (17)
Biliary cystadenoma with intratumoral bleeding: radiologic-pathologic correlation. (1991) (17)
Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms (2014) (17)
Features Suggestive of Gallbladder Malignancy: Analysis of T1, T2, and T3 Tumors on Cross-Sectional Imaging (2014) (17)
Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid. (2018) (17)
Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. (2007) (16)
Mesenteric panniculitis presenting as a multilocular cystic mesenteric mass: CT and MR evaluation. (1993) (16)
Gene Expression in Neoplasms of the Pancreas: Applications to Diagnostic Pathology (2003) (16)
Acinar Cell Carcinoma With Prominent Intraductal Growth Pattern (2011) (16)
Cancerization of the Pancreatic Ducts (2018) (16)
Accuracy of apparent diffusion coefficient in differentiating pancreatic neuroendocrine tumour from intrapancreatic accessory spleen (2018) (16)
N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN (2015) (16)
Serous Cystadenoma of the Pancreas: Potentials and Pitfalls of a Preoperative Cytopathologic Diagnosis (2016) (16)
Differentiating intraductal papillary mucinous neoplasms from other pancreatic cystic lesions. (2010) (16)
Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. (1998) (16)
Intrapancreatic Accessory Spleen: Possibilities of Computed Tomography in Differentiation From Nonfunctioning Pancreatic Neuroendocrine Tumor (2014) (15)
Pancreatic cancer: From genes to patient care (2001) (15)
Treatment of familial pancreatic cancer and its precursors (2005) (15)
Follow-up of Incidentally Detected Pancreatic Cystic Neoplasms: Do Baseline MRI and CT Features Predict Cyst Growth? (2019) (15)
23Na MRI combined with contrast‐enhanced 1H MRI provides in vivo characterization of infarct healing (2005) (15)
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer. (2014) (15)
Differential expression of multiple genes in association with MADH4/DPC4/SMAD4 inactivation in pancreatic cancer. (2008) (15)
Glomus Tumor of the Stomach: Depiction by Multidetector CT and Three-Dimensional Volume Rendering Imaging (2010) (15)
Breast carcinoma metastatic to the esophagus. CT findings with pathologic correlation. (1998) (15)
Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). (2012) (15)
Copy‐number methods dramatically underestimate loss of heterozygosity in cancer (2006) (15)
Current topics on precursors to pancreatic cancer. (2006) (15)
Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation (2015) (15)
Accelerated arteriosclerosis in heart transplant recipients: an immunopathology study of 22 transplanted hearts. (1991) (15)
Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance (2018) (15)
Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012 (2013) (15)
A "Clearer" View of Pancreatic Pathology: A Review of Tissue Clearing and Advanced Microscopy Techniques. (2019) (15)
Intrahepatic cholangiocarcinoma: findings on spiral CT during arterial portography. (1994) (14)
The foamy variant of pancreatic intraepithelial neoplasia. (2008) (14)
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary (2018) (14)
Perforin Expression in Human Cell‐Mediated Luteolysis (1995) (14)
Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome. (2018) (14)
Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation (2020) (14)
A proposed clinical test for monitoring fluoropyrimidine therapy: Detection and stability of thymidylate synthase ternary complexes (2006) (13)
Familial pancreatic cancer: from genes to improved patient care (2007) (13)
FAM190A Rearrangements Provide a Multitude of Individualized Tumor Signatures and Neo-antigens in Cancer (2011) (13)
Smoking Is Not Associated with Severe Dysplasia or Invasive Carcinoma in Resected Intraductal Papillary Mucinous Neoplasms (2014) (13)
Endobronchial metastasis. (1993) (13)
Aortic dissection in a cardiac allograft recipient: a case report. (1995) (13)
Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls (2020) (13)
A small cell carcinoma of the pancreas with a high level of serum ProGRP. (2004) (13)
Management of pancreatic cysts: a multidisciplinary approach (2013) (13)
Colonic Endometriosis Mimicking Colon Cancer on a Virtual Colonoscopy Study: A Potential Pitfall in Diagnosis (2009) (13)
In vivo and in vitro Propagation of Intraductal Papillary Mucinous Neoplasms (2010) (13)
Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. (1999) (13)
Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements. (2021) (12)
Pathobiology of cancer of the pancreas (1995) (12)
Novel homozygous deletions of chromosomal band 18q22 in pancreatic adenocarcinoma identified by STS marker scanning (1999) (12)
Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma (2016) (12)
Fas-mediated apoptosis in accelerated graft arteriosclerosis (2004) (12)
Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations that Improve the Clinical Management of Pancreatic Cysts. (2022) (12)
The pigmented “black” neuroendocrine tumor of the pancreas (2001) (12)
Small Bowel Gastrointestinal Stromal Tumors: Multidetector Computed Tomography Enhancement Pattern and Risk of Progression (2017) (12)
Frequent germline deletion polymorphism of chromosomal region 8p12-p21 identified as a recurrent homozygous deletion in human tumors. (2001) (12)
A prospective validation of a direct tumor xenograft model in pancreatic ductal adenocarcinoma (PDA) (2008) (12)
Three‐dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding (2020) (11)
Computed tomography of rounded atelectasis. (1988) (11)
Multiple Endocrine Neoplasms and Serous Cysts of the Pancreas in a Patient with von Hippel-Lindau Disease (2010) (11)
Hepatic adenomatosis: spectrum of imaging findings (2013) (11)
Ossification of a rectal tumor: CT evaluation. (1997) (11)
Krukenberg Tumors: CT Features and Growth Characteristics (1989) (11)
The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipients. (1996) (11)
Inhibition of Accelerated Graft Arteriosclerosis by Gene Transfer of Soluble Fibroblast Growth Factor Receptor-1 in Rat Aortic Transplants (2004) (11)
IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth (2017) (11)
Use and benefits of a Web site for pancreatic cancer. (1998) (11)
CT of gallbladder cancer and its mimics: a pattern-based approach (2013) (11)
Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia. (2016) (11)
Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes (2018) (11)
Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours. (2020) (10)
Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants (2019) (10)
Pancreatic Cancer Imaging: A New Look at an Old Problem. (2020) (10)
Clinical applications of detecting dysfunctional p53 tumor suppressor protein. (1999) (10)
Inflammatory pseudotumor of the terminal ileum mimicking malignancy in a patient with Behçet's disease. CT and pathological findings. (1996) (10)
CT features of pulmonary artery sarcoma: critical aid to a challenging diagnosis (2010) (10)
Radiation in the management of pancreatic neuroendocrine tumors. (2012) (10)
Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma (2012) (10)
Adenocarcinoma of the pancreas: Factors influencing outcome after pancreaticoduodenectomy - The Johns Hopkins experience (1994) (10)
Lessons learned from 29 lymphoepithelial cysts of the pancreas: institutional experience and review of the literature. (2018) (10)
The Evolution of Earned, Transparent, and Quantifiable Faculty Salary Compensation (2018) (10)
Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (2018) (9)
Angioleiomyoma involving the sciatic nerve--CT demonstration. Case report. (1993) (9)
The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer (2021) (9)
Acinar cell carcinoma of the pancreas: a clinicopathologic and cytomorphologic review. (2020) (9)
Folliculo-stellate cells in the human anterior pituitary express cytokeratin. (1993) (9)
CODA: quantitative 3D reconstruction of large tissues at cellular resolution (2022) (9)
Diagnosis andManagement of Cystic Lesions of the Pancreas (2014) (9)
Adenocarcinoma of the Hepatopancreatic Ampulla in a Domestic Cat (1996) (9)
CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma. (2021) (9)
Detection of early-stage pancreatic carcinoma. (2009) (9)
Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers (2020) (9)
The “Race” Toward Diversity, Inclusion, and Equity in Pathology: The Johns Hopkins Experience (2019) (9)
Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma (2017) (9)
Presence of Pancreatic Intraepithelial Neoplasia in the Pancreatic Transection Margin does not Influence Outcome in Patients with R0 Resected Pancreatic Cancer (2011) (9)
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017 (2020) (9)
Comparison of rejection in the atrioventricular node and bundles with the working myocardium in transplanted hearts. (1991) (9)
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature (2015) (9)
Morphologic basis of MR imaging of benign prostatic hyperplasia. (1987) (9)
415g: Screening for Familial Pancreatic Neoplasia:a Prospective, Multicenter Blinded Study of EUS, CT, and Secretin-MRCP (The NCI-Spore Lustgarten Foundation Cancer of the Pancreas CAPS 3 Study) (2010) (9)
Autoimmune pancreatitis: Current diagnostic criteria are suboptimal (2011) (9)
Pancreatic Intraepithelial Neoplasia. (2011) (8)
Absorbable suture improves growth of venous anastomoses. (1992) (8)
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer. (2017) (8)
Tumor suppressive pathways in pancreatic cancer (1997) (8)
Virus-associated RNAs (VA-I and VA-II). An efficient target for the detection of adenovirus infections by in situ hybridization. (1992) (8)
Diagnosis: A step closer to screening for curable pancreatic cancer? (2015) (8)
Added value of apparent diffusion coefficient in distinguishing between serous and mucin-producing pancreatic cystic neoplasms (2019) (8)
Second primary lesions in the biliary tree after successful resection of ampullary carcinoma. (1992) (8)
Multi-Detector Row CT of Pancreatic Islet (2006) (8)
Pancreatic cancer. Special issue--insights and controversies in pancreatic pathology. (2009) (8)
Incidentally detected pancreatic neuroendocrine microadenoma with lymph node metastasis (2018) (8)
Erratum: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse (Cancer Cell (4) (437-450)) (2004) (8)
Progression Model for Pancreatic Cancer 1 (2000) (8)
Genius on the Edge: The Bizarre Double Life of Dr. William Stewart Halsted (2011) (8)
Hemorrhagic infarction of hilar lymph nodes associated with combined heart-lung transplantation. (1990) (8)
Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype (2018) (8)
Cerebral cysticercosis mimicking malignant glioma: a case report. (1996) (8)
Preliminary Results of a Pilot Study Evaluating An Allogeneic GM-CSF Pancreatic Tumor Cell Vaccine (GVAX) and Cytoxan (Cy) With Stereotactic Body Radiation Therapy (SBRT) and Folfirinox (FFX) in Patients With Resected Pancreatic Adenocarcinoma (2015) (8)
Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma (2021) (8)
Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort (2018) (7)
A robust non-linear tissue-component discrimination method for computational pathology (2015) (7)
Transflip mutations produce deletions in pancreatic cancer (2015) (7)
Screening for Pancreatic Cancer Gets a D, But the Student Is Improving. (2019) (7)
Alterations of type II classical cadherin, cadherin‐10 (CDH10), is associated with pancreatic ductal adenocarcinomas (2017) (7)
Comparison of intra-arterial and intravenous infusion of cisplatin for head and neck squamous cell carcinoma in a modified rat model. (1993) (7)
Advances in Brief The Incidence of p 53 Mutations Increases with Progression of Head and Neck Cancer (2007) (7)
Intrathoracic paraspinal desmoid with intracanalicular extension: computed tomography and magnetic resonance imaging findings. (2000) (7)
Pancreaticoduodenectomy and palliation in pancreatic carcinoma. (1997) (7)
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas (2017) (7)
Preproenkephalin and p16 gene CpG island hypermethylation in pancreatic intraepithelial neoplasia (PanIN) and invasive ductal adenocarcinoma (2002) (7)
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity (2022) (7)
Olive , Cancer of Chemotherapy in a Mouse Model of Pancreatic Inhibition of Hedgehog Signaling Enhances Delivery (2009) (7)
Complement as a mediator of allograft injury: an inflammatory view (2000) (7)
GNAS Codon 201 mutations are uncommon in Intraductal Papillary Neoplasms of the Bile Duct (2012) (6)
Detection of the Human Cytomegalovirus 2.0-kb Immediate Early Gene 1 Transcripts in Permissive and Nonpermissive Infections by RNA in situ Hybridization. (1997) (6)
Screening for Pancreatic Neoplasia in Asymptomatic High Risk Individuals: A Prospective, Controlled Study (2004) (6)
Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma. (2020) (6)
Tumor‐Associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: An immunohistochemical study using the monoclonal antibody B72.3 (1994) (6)
Screening for Pancreatic Cancer-Is There Hope? (2019) (6)
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer (2021) (6)
Intraductal Pancreatic Cancer is Less Responsive Than Cancer in the Stroma to Neoadjuvant Chemotherapy (2020) (6)
Hypermethylation of Multiple Genes in Pancreatic Adenocarcinoma 1 (2000) (6)
Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News. (2019) (6)
The genetic classification of pancreatic neoplasia (2015) (6)
Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors (2020) (6)
DETECTION OF CIRCULATING TUMOR DNA IN PATIENTS WITH PANCREATIC CANCER USING DIGITAL NEXT-GENERATION SEQUENCING. (2020) (6)
Diagnosis of rejection of lung allografts. (1988) (6)
Pancreaticoduodenectomy (Whipple Resections) in Patients Without Malignancy (2002) (6)
Case report 505 (2004) (6)
Recurrent fibromatosis in a patient with breast carcinoma. Computed tomography findings with magnetic resonance imaging and pathologic correlation. (1995) (6)
Evidence that the expression of class II MHC antigens is not diagnostic of lung allograft rejection. (1989) (6)
FETAL ANOMALIES ASSOCIATED WITH AN INVERSION DUPLICATION 13 CHROMOSOME (1988) (6)
Uterus, Cervix, and Vagina (2003) (6)
High resolution computed tomography of inflation-fixed lungs: pathologic-radiologic correlation of pulmonary lesions in patients with leukemia, lymphoma, or other hematopoietic proliferative disorders. (1992) (6)
Prognostic significance of the labeling of Adnab-9 in pancreatic intraductal papillary mucinous neoplasms (2001) (6)
Partial T-cell receptor gene rearrangement. A source of pseudo-clonal populations in thymomas and other thymic tissues. (1996) (5)
Methylation of Cyclin D 2 Is Observed Frequently in Pancreatic Cancer but Is Also an Age-related Phenomenon in Gastrointestinal Tissues 1 (2003) (5)
Endoluminal sealing of vascular wall disruptions with radiofrequency-heated balloon angioplasty. (1993) (5)
Pathology of pancreatic cancer (2008) (5)
Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications. (2020) (5)
Homozygous Deletion Map at 18 q 21 . 1 in Pancreatic Cancer 1 (2006) (5)
Multiple KRAS mutations in the non‐mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas (2019) (5)
Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy (2017) (5)
p 53 Mutations in Pancreatic Carcinoma and Evidence of Common Involvement of Homocopolymer Tracts in DNA Microdeletions 1 (2006) (5)
Surgical Pathology Dissection (2003) (5)
Molecular genetics of pancreatic adenocarcinoma (1994) (5)
Detection of a neuron-specific 9.0-kb transcript which shares homology with antisense transcripts of HIV-1 gag gene in patients with and without HIV-1 infection. (1993) (5)
764 International Consensus Recommendations on the Management of Patients With Increased Risk for Familial Pancreatic Cancer: Cancer of the Pancreas Screening Consortium (CAPS) 2011 Summit (2012) (5)
Erratum: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study (Virchows Archiv (2005) 447 (794-799) DOI: 10.1007/s00428-005-0039-7) (2012) (5)
The Johns Hopkins Department of Pathology Novel Organizational Model: A 25-Year-Old Ongoing Experiment (2018) (5)
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. (2014) (5)
Prognostic significance of the labeling of Adnab-9 in pancreatic intraductal papillary mucinous neoplasms. (2001) (5)
Atlas of Pancreatic Cytopathology: With Histopathologic Correlations (2009) (5)
ACCELERATED GRAFT ARTERIOSCLEROSIS IN CARDIAC TRANSPLANTS (2001) (5)
Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation. (2015) (5)
Genetically defined subsets of human pancreatic cancer demonstrate unique in vitro chemosensitivity (2012) (5)
Preoperative Detection of Familial Pancreatic Neoplasms By Endoscopic Ultrasonography (EUS), Multidetector Computed Tomography (CT), and/Or Magnetic Resonance Cholangiopancreatography (MRCP) (2008) (4)
Gastric cancer following pancreaticoduodenectomy: Experience from a high-volume center and review of existing literature (2020) (4)
Advances in Brief Detection of Mitochondrial DNA Mutations in Pancreatic Cancer Offers a “ Mass ”-ive Advantage over Detection of Nuclear DNA Mutations 1 (2001) (4)
Bronchioalveolar Carcinoma: Emphasis on Localized Lesions (1989) (4)
Short Communication Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma (2002) (4)
Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas. (2020) (4)
Guidelines for the Use of Tumor Markers in Pancreatic Ductal Adenocarcinoma (2006) (4)
Classification of pancreatic cystic neoplasms using radiomic feature analysis is equivalent to an experienced academic radiologist: a step toward computer-augmented diagnostics for radiologists (2022) (4)
Predictors of Neoplastic Progression in High-Risk Individuals Undergoing Surveillance for Pancreatic Cancer: Lessons from the First 16 Years of the Cancer of the Pancreas Screening (CAPS) Program (2017) (4)
The Pathology Residency Program of the Johns Hopkins University School of Medicine: a model of its kind. (2015) (4)
Comparison of myocardial oxygen consumption using 11C acetate positron emission tomography scanning in a working and non-working heart transplant model. (2001) (4)
Case report 505: Malignant fibrous histiocytoma of thigh and liposarcoma in same lower extremity (synchronous lesions). (1988) (4)
Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer (2017) (4)
Solid Serous Adenoma of the Pancreas: Clinicopathologic Features and Differential Diagnosis (2010) (4)
Pancreatic volume does not correlate with histologic fibrosis in adult patients with recurrent acute and chronic pancreatitis. (2020) (4)
Correlation of DPC4 status with outcomes in pancreatic adenocarcinoma patients receiving adjuvant chemoradiation. (2011) (4)
Pathology and Classification of Cystic Tumors of the Pancreas (2016) (4)
Molecular Diagnosis of Cancer and Micrometastases (1998) (3)
Generation and characterization of a cell line from an intraductal tubulopapillary neoplasm of the pancreas (2020) (3)
History of the Pancreas: Mysteries of a Hidden Organ (review) (2004) (3)
Downregulation of 5‐hydroxymethylcytosine is an early event in pancreatic tumorigenesis (2021) (3)
[Hepatic angiomyolipoma. Magnetic resonance imaging and imaging by CT-xray]. (1995) (3)
A Semicentennial of Pancreatic Pathology: The Genetic Revolution Is Here, But Don't Throw the Baby Out With The Bath Water! (2019) (3)
Is surgery required for patients with intraductal papillary mucinous neoplasms without mural nodules? (2008) (3)
Hepatocellular carcinoma: Findings on spiral CT during arterial portography (1995) (3)
Pancreatic Nerve Sheath Tumors: a Single Institutional Series and Systematic Review of the Literature (2019) (3)
The tail of neuroendocrine tumors from lung to pancreas: Two rare case reports (2014) (3)
CT evaluation of thymoma: Spectrum of disease (1997) (3)
Screening for Pancreatic Cancer Using Techniques to Detect Altered Gene Products (1998) (3)
Effective gene transfer in the rat myocardium via adenovirus vectors using a coronary recirculation model. (1999) (3)
Mediastinal involvement by alveolar rhabdomyosarcoma: evaluation with computerized tomography. (1991) (3)
The Genetic Basis of Transcriptional Heterogeneity for Basal-Like Features in Pancreatic Ductal Adenocarcinoma (2019) (3)
Pancreatic cancer pathology viewed in the light of evolution (2021) (3)
Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer. (2015) (3)
Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers (2017) (3)
Three-dimensional imaging of the lung in vivo: Work in progress (1991) (3)
Pancreatic Imaging (2017) (3)
Abstract 619: Identification of clinically actionable genomic alterations in the tumor and circulation of pancreatic cancer patients (2015) (3)
The FELIX Project: Deep Networks To Detect Pancreatic Neoplasms (2022) (3)
146: Adjuvant Chemoradiation for Adenocarcinoma of the Pancreas: The Johns Hopkins Experience (2006) (3)
Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy (2022) (3)
Baseline Hemoglobin-A 1 c Impacts Clinical Outcomes in Patients With Pancreatic Cancer (2014) (3)
Autoimmune pancreatitis with response to chemoradiation therapy. (2011) (3)
Short Communication STK11/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas (2001) (3)
Lymphocytic bronchitis and lung allograft rejection. (1990) (3)
Non-neoplastic Intestinal Disease (1996) (3)
General Approach to Surgical Pathology Specimens (2003) (3)
Bronchobiliary fistula and lithoptysis after endoscopic retrograde cholangiopancreatography and liver biopsy in a patient with paroxysmal nocturnal hemoglobinuria. (2013) (2)
Invasive and Noninvasive Progression After Resection of Noninvasive Intraductal Papillary Mucinous Neoplasms (2020) (2)
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds. (2022) (2)
Is successful resection following neoadjuvant radiation therapy for borderline resectable pancreatic cancer dependent on improved tumor-vessel relationships? (2013) (2)
Ovary and Fallopian Tube (2003) (2)
Splenic abscess as a complication of septic yersinia: CT evaluation. (1993) (2)
Cystic lesions of the pancreas. (2008) (2)
Globular changes in cytomegaloviral inclusions after Ganciclovir treatment (1989) (2)
Corrigendum: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma (2013) (2)
Spotlight on Clinical Response Personalizing Cancer Treatment in the Age of Global Genomic Analyses : PALB 2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer (2011) (2)
Case report 852 (1994) (2)
ROR1 and ROR2 expression in pancreatic cancer (2021) (2)
Hearts lacking donor-type APCs develop cardiac allograft vasculopathy. (1999) (2)
Erratum to "Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation" [Diagn. Interv. Imaging. 101 (2020) 35-44]. (2020) (2)
Predictive Biomarkers and Personalized Medicine Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer (2011) (2)
High Resolution 31) 1H Contrast Enhanced MR Imaging in Reperfused Myocardial Infarction: A Histopathologic Correlation (1999) (2)
Detection of early-stage pancreatic ductal adenocarcinoma (PDAC): Sensitivity, specificity, and discriminatory properties of the serum-based PAM4-immunoassay. (2012) (2)
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. (2016) (2)
Primary pancreatic Ewing sarcoma: a cytomorphologic and histopathologic study of 13 cases. (2020) (2)
New aspects of genetics and surgical management in pancreatic cancer: The Johns Hopkins experience (1997) (2)
Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving Field (2021) (2)
MITOCHONDRIAL NADH - UBIQUINONE OXIDOREDUCTASE (Complex 1) DEFICIENCY IN AN INFANT WITH CONGENITAL LACTIC ACIDOSIS (1984) (2)
Grading pulmonary rejection: a proposal for a simplified system. (1994) (2)
A multivariate model for identifying risk of early death after Pancreaticoduodenectomy(PDD) and adjuvant therapy for periampullary Adenocarcinoma(PA): importance for understanding post treatment outcomes (2002) (2)
Phase II study of erlotinib combined with adjuvant chemoradiation and chemotherapy for resectable pancreatic cancer. (2013) (2)
A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review (2017) (2)
Non-functioning (non-syndromic) neuroendocrine tumours (2017) (2)
Guest Reviewer (2000) (2)
Gastric Heterotopic Pancreas: Computed Tomography With Clinicopathologic Correlation (2017) (2)
Pathology of intraductal papillary mucinous neoplasms (2021) (2)
Current Status of Radiomics and Deep Learning in Liver Imaging (2021) (2)
Endoplasmic stress‐inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case‐control study and meta‐analysis (2021) (2)
316 The Phenotype of Familial Pancreatic Neoplasia (2008) (2)
Case 7-2004: hereditary melanoma and pancreatic cancer. (2004) (2)
W1682 Tumor Size Correlates With Lymph Node Metastasis in Primary Pancreatic Endocrine Neoplasms (2010) (2)
PAM 4 Immunoassay Alone and in Combination with CA 19-9 for the Detection of Pancreatic Adenocarcinoma (2013) (2)
A Metastasis Caught in the Act (1996) (2)
Molecular Mechanisms of Cystic Neoplasia (2018) (2)
Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture. (2019) (2)
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. (2022) (2)
COMPLEMENT MEDIATES VASCULAR INFLAMMATION AND ACTIVATION IN ALLOGRAFTS. (1999) (2)
Expression Profiling of Pancreatic Ductal Adenocarcinoma (2003) (2)
Soft Tissue, Nerves, and Muscle (1996) (1)
Long-term outcomes with neoadjuvant chemotherapy with or without stereotactic body radiation therapy in patients with borderline resectable and locally advanced pancreatic adenocarcinoma. (2021) (1)
First report of the correlation of PET Response Criteria in Solid Tumors (PERCIST) criteria and pathologic change in patients with rectal cancer treated with neoadjuvant radiation. (2013) (1)
Fluorescence in situ hybridization (fish) analysis of pancreatic adenocarcinoma (1993) (1)
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancer. (2023) (1)
Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma. (2020) (1)
Surgical management of gastrointestinal stromal tumors: A single institution 31 — Year experience (2001) (1)
A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review. (2017) (1)
Case report 535 (2004) (1)
Identification and Characterization of Differentially Methylated CpG Islands in Pancreatic Carcinoma 1 (2001) (1)
Abstract IA17: Non-invasive detection of somatic mutations in the management of CRC (2017) (1)
Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM). (2019) (1)
Surgical Pathology Specimen Orientation Markers (1993) (1)
Complement deposition is more frequent in female recipients of cardiac transplants (2002) (1)
Association of recurrence patterns following resection of pancreatic adenocarcinoma with overall survival. (2014) (1)
MicroRNA and Gene Expression Profiling in Syndromic and Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors: An Integrated Analysis (2016) (1)
Corrigendum: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma (1994) (1)
A Department-Sponsored, Hospital-Based Pathology Education Symposium Is a Cost-Effective Method to Provide Laboratory Staff With Highly Rated Continuing Education Experiences. (2020) (1)
Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine (2017) (1)
A new marker for pancreatic cancer (2001) (1)
Patient retention and costs associated with a pancreatic multidisciplinary clinic. (2012) (1)
T1376 Location and Size Predict Invasiveness of Pancreatic Serous Cystic Neoplasms (2010) (1)
SPONTANEOUS DEVELOPMENT OF MURINE PANCREATIC INTRAEPITHELIAL NEOPLASIA (MPANIN) IN ELA-CREERT2; LSL-KRASG12D MICE: INSIGHTS INTO CELLULAR ORIGINS OF PANCREATIC CANCER (2007) (1)
Investigational strategies for detection and intervention in early-stage pancreatic cancer (1994) (1)
Predictors, Patterns, and Timing of Recurrence Provide Insight into the Disease Biology of Invasive Carcinomas Arising in Association with Intraductal Papillary Mucinous Neoplasms (2022) (1)
Efficacy of Platinum Chemotherapy Agents in the Adjuvant Setting for Adenosquamous Carcinoma of the Pancreas (2013) (1)
Genomic Applications in Pancreatic and Gastric Tumors (2018) (1)
Hemoglobin-A1c level to predict for clinical outcomes in patients with pancreatic cancer. (2013) (1)
Abstract B16: Using human patient-derived organoids to identify genetic dependencies in pancreatic cancer (2016) (1)
Case report 535: Hepatoma metastatic to the sternum. (1989) (1)
Resections for Inflammatory Bowel Disease/Resections of Intestinal Neoplasms (1996) (1)
P028) Patient Retention After Initial Consultation Results in Extended Survival in Pancreatic Cancer (2017) (1)
Anti-thymocyte globulin treatment is associated with complement deposition in early cardiac transplant biopsies. (2001) (1)
Carcinoid Tumors of the Extrahepatic Bile Ducts (2000) (1)
with Congenital Lactic Acidosis (1984) (1)
Development of a biological resource for genomic characterisation of pancreatic cancer (2009) (1)
Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer. (2021) (1)
Terminal complement proteins in mediating processes of accelerated graft arteriosclerosis in cardiac transplants. (2001) (1)
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1). (2022) (1)
Abstract 2628: Genome-wide sequencing identifiesATMas a pancreatic cancer susceptibility gene (2012) (1)
The Proportional Odds Model for Assessing Rater Agreement with Multiple Modalities (2004) (1)
Metastatic adenocarcinoma of the prostate: presentation as a pleural-based mass. (1993) (1)
Combination of the PAM4 and CA19-9 biomarkers to improve the detection of pancreatic adenocarcinoma. (2012) (1)
Comprar Atlas of Pancreatic Cytopathology: With Histopathologic Correlations | Ralph H Hruban | 9781933864402 | Demos Medical Publishing (2009) (1)
Silverberg's Principles and Practice of Surgical Pathology and Cytopathology: The pancreas and extrahepatic biliary system (2015) (1)
Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance (2022) (1)
Tu1560 EUS Accurately Predicts Endoscopic Local Resectability Regardless of Tumor Size (2012) (1)
Among pancreatic adenocarcinomas treated by whipple resection, an intact DPC4 portends a significantly improved patient survival (2001) (1)
T2095 Assessment of “Gene-Environment” Interaction in Cases of Familial and Sporadic Pancreatic Cancer (2008) (1)
Neoplasms of the Neuroendocrine Pancreas: Non-functioning (non-syndromic) neuroendocrine tumours (2017) (1)
Novel Use of a Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum for Radiation Therapy for Pancreatic Cancer (2017) (1)
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma (2018) (1)
KAI 1 Metastasis Suppressor Protein in Cervical Cancer (2002) (1)
Non-neoplastic and neoplastic pathology of the pancreas (2012) (1)
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association (2021) (1)
Molecular biology of pancreas cancer (2015) (1)
Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
AB113. P087. Single-cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions (2018) (1)
Endoscopic Ultrasound (EUS), Chronic Pancreatitis, and Pancreatic Cancer (PC) Precursors in High Risk Individuals (2006) (1)
1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS (2019) (1)
Signi fi cance of the Genetic Landscape of Pancreatic Cancer and Implications for Identi fi cation of Potential Long-term Survivors (2012) (0)
AUTOANTIBODIOMICS APPROACH IDENTIFYING NOVEL ANTIBODIES IN PATIENTS WITH PANCREATIC CANCER (2008) (0)
Tu1866 Quality of Life and Cancer Worry of Individuals With Increased Risk for Familial Pancreatic Cancer (2013) (0)
Ovarian Metastasis from Pancreatic Ductal Adenocarcinoma (2021) (0)
Genomic Applications in Colorectal and Pancreatic Tumors (2015) (0)
Correlation between pancreatic tumor size as measured on 3D CT scan versus pathologic specimen: Impact on radiation treatment volume. (2011) (0)
John M. Howard and Walter Hess. History of the Pancreas: Mysteries of a Hidden Organ (2004) (0)
Case report 854: Eosinophilic granuloma. (1994) (0)
Femoral Head/Bone Tumors (1996) (0)
Identifying Markers for Pancreatic Cancer by Gene (2017) (0)
Diagnostic et therapies d'un cancer du pancreas (2002) (0)
Against Coxsackievirus Pancreatitis Inducible Nitric Oxide Synthase Protection (1999) (0)
Hereditary Pancreatic Cancer: Part II. Candidate Genes (1997) (0)
Molecular Genetics of Neuroendocrine Tumors (2018) (0)
Small Brain Biopsies for Glial Neoplasms/Thyroidectomy (1996) (0)
CHAPTER 26 – Pancreas (2009) (0)
Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer: 3-Year Update (2013) (0)
Small Cell Carcinoma of the Gallbladder (2001) (0)
Complex karyotypes consistently found in most adenocarcinomas of the pancreas (1997) (0)
Hysterectomy for Endometrial Cancer/Hysterectomy for Nonmaligant Disease (1996) (0)
Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication (2020) (0)
Radical Neck Dissection (2003) (0)
The Digital Pathology Association's Annual Conference October 1-3 | Manchester Grand Hyatt | San Diego, CA (2017) (0)
Ewing et al. Suppl. Data 1 (2015) (0)
EVALUATING THE IMPACT OF A MULTIDISCIPLINARY SINGLE DAY CLINIC ON THE MANAGEMENT OF PANCREATIC CANCER (2007) (0)
Compliment deposition in early cardiac transplant biopsies is associated with ischemic injury. (1999) (0)
Adnab-9, a prognostic marker in pancreatic neoplasia (2000) (0)
Palliative surgery in advanced pancreatic cancer. Chapter 36 in Handbook of Pancreatic Cancer (2005) (0)
Total Pelvic Exenteration/Radical Hysterectomy for Cervical Cancer (1996) (0)
T2086 Hypermethylation of Multiple Genes in Intraductal Papillary Mucinous Neoplasm of Pancreas (2008) (0)
Loss of heterozygosity and microsatellite instability in gastric stump carcinomas (2000) (0)
Intraductal Papillary Mucinous Neoplasm in Patients Under age 50: Tumor Biology, Clinical Features, Recurrence Rates, and Survival Outcomes (2017) (0)
Serum Protein Expression and Associations With Conversion to Resectable Status Following Chemotherapy and Stereotactic Body Radiation Therapy in Locally Advanced Pancreatic Adenocarcinoma (2016) (0)
Computational discovery of tissue morphology biomarkers in very long-term survivors with pancreatic ductal adenocarcinoma (2017) (0)
Tissue Collection for Molecular Genetic Analysis (2003) (0)
Apoptosis and early necrosis in peritransplant ischemic injury and acute allograft rejection in human heart transplant recipients (1998) (0)
Case report 612 (1990) (0)
Abstract 2735: Inactivation of activin signaling pathway accelerates the development of pancreatic intraductal papillary mucinous neoplasms in vivo. (2013) (0)
Supplemental Information Genomic Sequencing Identi fi es ELF 3 as a Driver of Ampullary Carcinoma (0)
Mo1396 EUS-FNA for Diagnosis and Risk Assessment of Gastrointestinal Stromal Tumors (GISTs) (2014) (0)
Fundamentals of Specimen Dissection/Photography (1996) (0)
Classification Map Identifying Tumor Origin Using a Gene Expression-based Updated Version (2003) (0)
Creation of a Z-Stacked Digital Image Database From Fine-Needle Aspiration Specimens of Solid Lesions of the Pancreas (2019) (0)
Intraductal papillary mucinous neoplasms in young patients have different epithelial subtypes and a more favorable prognosis (2017) (0)
COAGULATION MARKERS PREDICTING CARDIAC TRANSPLANT REJECTION1 (2001) (0)
Abstract 17: Proteogenomic characterization of pancreatic ductal adenocarcinoma (2021) (0)
Bone Marrow Aspirate/Lymph Nodes (1996) (0)
Pathologic quiz case 2. Pneumocystis carinii infection of the external auditory canal. (1993) (0)
Dr. Groven M. Hutchins (2011) (0)
Pancreatoblastoma in an elderly woman: A case report simulating a pancreatic neuroendocrine tumour with emphasis on cytomorphological features (2022) (0)
Abstract 2404: Increased mitochondrial DNA copy number occurs during prostate cancer progression and in cancer precursor lesions across multiple organs (2021) (0)
Oncologic Resection of Pancreatic Cancer with Isolated Liver Metastasis: Favorable Outcomes in Select Patients. (2023) (0)
TOLERANCE INDUCTION IN RATS DOES NOT REQUIRE GRAFT RESIDENT DONOR-TYPE ANTIGEN PRESENTING CELLS (1998) (0)
Identification of diagnostic and therapeutic targets of pancreatic cancer using proteomic approaches (2009) (0)
Skin/Soft Tissue Tumor Resections (1996) (0)
Origins of pancreatic cancer: recently defined putative precursor lesions (2001) (0)
Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
QS322. Is it Safe to Observe Asymptomatic Branch Duct or Mixed-Type Intraductal Papillary Mucinous Neoplasms (IPMN) Less Than 3CM and Without a Solid Component?: The Pathological Findings of 16 Patients Who Underwent Pancreatectomy for This Condition (2009) (0)
Abstract IA5: Translating genetic discoveries to patient care (2015) (0)
Hereditary Pancreatic Cancer: Part I. The Genetic Profile (1997) (0)
SURVEILLANCE OF HIGH-RISK INDIVIDUALS LEADS TO LOWER STAGE PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) AT DIAGNOSIS AND IMPROVED OVERALL AND DISEASE-SPECIFIC SURVIVAL (2022) (0)
Modeling early genomic events of pancreatic cancer using CRISPR/Cas9 (2019) (0)
207 A phase II study of intensified adjuvant therapy for resected pancreatic and other periampullary adenocarcinoma using radiation, 5Fu, leucovorin, dipyridamole and mitomycin-C (1999) (0)
Skeletal Radiology Case report 612 (0)
Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: Impact of family history on outcome (2007) (0)
Erratum to: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study (2012) (0)
Common Uncomplicated Specimens (2003) (0)
ection of Early-Stage Pancreatic Adenocarcinoma (2010) (0)
Mutations in the pancreatic secretory enzymes and are associated with pancreatic cancer. (2018) (0)
Case report 852. Periosteal osteosarcoma of femur. (1994) (0)
Cytogenetic analysis of epithelial pancreatic neoplasms (1997) (0)
Johns Hopkins Hospital notables portrayed on philatelic material (2011) (0)
Partial Hepatectomy/Total Hepatectomy (1996) (0)
identifying cancer patients from GC-patterned fragment ends of cell-free DNA (2022) (0)
Neoplastic Intestinal Disease (1996) (0)
Pancreas and Biliary Tree (2015) (0)
Regarding the article entitled 'Massive retroperitoneal angiomyolipoma: A lesion that may be confused with well-differentiated liposarcoma' (I: Reply) (1990) (0)
FOLLICULAR THYROID NEOPLASMS. AUTHORS' REPLY (1991) (0)
PrimaryPneumocystic carinii infection of the small bowel: Presentation as an acute abdomen (1998) (0)
Case report 769. Fibrous dysplasia. (1993) (0)
Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma—two case reports (2022) (0)
Prognostic factors after pancreaticoduodenectomy for duodenal adenocarcinoma: Results from a dual center analysis. (2014) (0)
Somatic protospacer adjacent motifs are numerous and selectively targetable in cancers (2023) (0)
Jeremy Jass Prize for Research Excellence in Pathology 2014 (2016) (0)
Frequent Intraluminal Growth of Large Muscular Veins in Surgically Resected Colorectal Cancer Tissues: A 3-Dimensional Pathologic Reconstruction Study. (2023) (0)
RNA Sequencing Identifies Frequent Mitogen Activated Protein Kinase-Associated Fusion Genes in Intraductal Tubulopapillary Neoplasms of the Pancreas. (2023) (0)
S1322 Autoimmune Pancreatitis: Application of Current Diagnostic Criteria Are Suboptimal (2008) (0)
HEARTS LACKING DONOR-TYPE ANTIGEN PRESENTING CELLS DEVELOP CARDIAC ALLOGRAFT VASCULOPATHY (1998) (0)
Abstract LB-191: Loss of the wild-typeKrasallele enhances the cellular proliferation and metastasis of pancreatic ductal adenocarcinomas in a conditionalP16andKras mutantmouse model (2010) (0)
229 - Surgical and Patient-Centered Outcomes after Pancreatic Resection in High-Risk Individuals for Pancreatic Cancer: A 20-Year Prospective Cancer of the Pancreas Screening (CAPS) Cohort Study (2018) (0)
594 CLINICAL SIGNIFICANCE OF SURVEILLANCE-DETECTED DUCTAL ABNORMALITIES IN INDIVIDUALS AT HIGH RISK FOR PANCREATIC CANCER (2020) (0)
Immunohistochemical Identification of Cytotoxic Lymphocytes (2007) (0)
Su1145 TUMOR SIZE, TUMOR STAGE, AND SURVIVAL OF HIGH RISK INDIVIDUALS WITH SURVEILLANCE-DETECTED PANCREATIC DUCTAL ADENOCARCINOMA (2020) (0)
Nuclear DNA Mutations Cancer Offers a ' ' Mass ' '-ive Advantage over Detection of Detection of Mitochondrial DNA Mutations in Pancreatic Updated (2001) (0)
Abstract IA-003: Proteogenomic characterizations of pancreatic ductal adenocarcinoma (2021) (0)
Non-invasive detection of bladder cancer through the analysis of driver gene 1 mutations and aneuploidy 2 3 (2017) (0)
Ewing et al. Suppl. Fig. 3 (2015) (0)
AB077. P049. Genetic relationship of pancreatic ductal adenocarcinoma and co-occurring IPMN (2018) (0)
Characterization of pancreatic serous cystadenoma on dual-phase multidetector computed tomography. (2014) (0)
IMMUNOHISTOCHEMICAL ANALYSIS SUGGESTS THAT ACUTE REJECTION OF MURINE CARDIAC ALLOGRAFTS LACKING DONOR-TYPE APCs PROCEEDS VIA THE INDIRECT PATHWAY (1998) (0)
Susceptibility and Prevention Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients (2009) (0)
Simulating Clinical Features of Pancreatic Cancer in a Mouse Model with Specific Genetic Alterations in Kras and p53 (2005) (0)
Activity of gemcitabine in direct patient-derived xenografts and clinical outcome: Validation of an in vivo model for drug development. (2009) (0)
Genome-WideAllelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms (2007) (0)
Differences in the pattern and timing of recurrence in patients after upfront or post-neoadjuvant pancreatectomy for pancreatic ductal adenocarcinoma (2018) (0)
Pathology of Exocrine Pancreatic Tumors (2018) (0)
Exomic sequencing of pancreatic neuroendocrine tumors: Detection of alterations in chromatin remodeling and mTOR pathway genes. (2011) (0)
The pancreas and extrahepatic biliary system (2015) (0)
1145 Detection and Treatment of Pancreatic Cancer and High-Grade Precursor Lesions in High-Risk Individuals Undergoing Surveillance: Results From the International CAPS Consortium Registry (2016) (0)
Hereditary pancreatic cancer (2011) (0)
A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO (2021) (0)
Myocardial Work-Load Significantly Affects Graft Atherosclerosis in Heterotopically Transplanted Rat Heart Allografts (1999) (0)
Case report 854 (2006) (0)
Heart Valves and Vessels (1996) (0)
A Department-Sponsored, Hospital-Based Pathology Education Symposium Is a Cost-Effective Method to Provide Laboratory Staff With Highly Rated Continuing Education Experiences. (2021) (0)
Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-Generation Sequencing (2014) (0)
Lobectomies and Pneumonectomies/Lobectomies and Pneumonectomies(Lung) (1996) (0)
Pancreatoblastoma in Elderly Adults: Report of Two Patients. (2022) (0)
Molecular Understanding of Development of Ductal Pancreatic Cancer (2018) (0)
Review Article Update on Pancreatic Intraepithelial Neoplasia (2008) (0)
Multiple Carcinomas and Intraepithelial Neoplasms in a Case of Familial Pancreatic Cancer: Rapid Morphological Changes in the Pancreatic Cyst and Pathological Lesions Undetected by Clinical Images (2020) (0)
Mixed Epithelial and Stromal Tumor of the Kidney: Radiologic- Pathologic Correlation1 (2010) (0)
Short Communication Detection of a Neuron-Specific 9.0-kb Transcript Which Shares Homology with Antisense Transcripts of HIV-1 gag Gene in Patients With and Without HIV-1 Infection (2007) (0)
Products of Conception and Placentas (2003) (0)
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease. (1997) (0)
The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience (2022) (0)
Su1154 WHEN SHOULD WE OPERATE ON PANCREATIC CYSTS DETECTED IN HIGH-RISK INDIVIDUALS (HRI)? VALIDATING PROPOSED CRITERIA FOR RESECTION USING INTERNATIONAL CONSENSUS GUIDELINES (ICG) AND INTERNATIONAL CANCER OF THE PANCREAS SCREENING (CAPS) CONSORTIUM STATEMENTS (2020) (0)
Radical Prostatectomy/Orchiectomy for Tumor (1996) (0)
Duodenal and ampullary carcinoid tumors: Using size to predict necessity for lymphadenectomy. (2013) (0)
597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts (2016) (0)
Case report 854 (1994) (0)
Acknowledgement to Reviewers (2007) (0)
High Grade Dysplasia And Invasive Carcinoma Among Sendai Negative Intraductal Papillary Mucinous Neoplasms (2020) (0)
Images in clinical medicine. A metastasis caught in the act. (1996) (0)
Cancer Therapy : Preclinical Personalized Chemotherapy Pro fi ling Using Cancer Cell Lines from Selectable Mice (2013) (0)
Dr. Patrick J. Fitzgerald, 1913–2004: An American Scholar (2005) (0)
Genomic Survey of Distal Bile Duct Carcinoma by Comparative Genomic Hybridization and Karyotype Analysis (2012) (0)
Case report 612: Rhabdomyosarcoma of the right psoas muscle. (1990) (0)
The pancreas cancer genome project (1997) (0)
Abstract 127: The genomic landscapes of inflammatory bowel disease-associated colorectal cancers (2016) (0)
Thee SMAD4 Protein and Prognosi s of Pancreatic Ductall Adenocarcinoma (2007) (0)
Correspondence re: M. S. van der Heijden et al., Fanconi Anemia Gene Mutations in Young-onset Pancreatic Cancer. Cancer Res., 63: 2585-2588, 2003 [2] (multiple letters) (2003) (0)
Major Salivary Glands (2003) (0)
Mechanism of delayed cell death following simultaneous CRISPR-Cas9 targeting in pancreatic cancers (2023) (0)
Poster Viewing AbstractMultiplex Proximal Ligation Assay Identifies Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy (2016) (0)
Pancreatic Cancer: Recognizing an Hereditary Predisposition (1997) (0)
with Phosphoserine Escherichia coli Expanding the Genetic Code of (2011) (0)
High concordance between DNA methylation of tumor suppressor loci in pancreatic cancer cell lines and their corresponding primary carcinoma (2000) (0)
Bi-allelic inactivation of the BRCA2 gene occurs after K-ras mutations in pancreatic precursor lesions from patients with germiline BRCA2 mutations (1998) (0)
AB097. P071. Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma (2018) (0)
Expression of hormones, chromogranin A and PDX1 by CD133+ cells following in vitro differentiation. (2015) (0)
Coexpression of neurogenin 3 (NGN3) and CD133 in cultured human exocrine tissue. (2015) (0)
Familial and sporadic pancreatic cancer share the same molecular pathogenesis (2014) (0)
AB095. P069. Identification of therapeutic genomic alterations by investigating cancer-related genes and microsatellite instability: road to precision medicine for pancreatic ductal adenocarcinoma (2018) (0)
Three-dimensional genomic mapping of human pancreatic tissue reveals striking multifocality and genetic heterogeneity in precancerous lesions (2023) (0)
Abstract 3935: CDKN2A/p16 is inactivated by the combination of inversion and translocation (2015) (0)
Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma (2022) (0)
Adrenalectomy/Nephrectomy for Tumor (1996) (0)
Sa299 NATURAL HISTORY OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS: A PROSPECTIVE STUDY (2021) (0)
Mastectomy/Breast Biopsy (1996) (0)
Penectomy/Total Vulvectomy (1996) (0)
University of Southern Denmark Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers (2018) (0)
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
Epigenetic silencing of the integrin α4 gene by hypermethylation in pancreatic ductal adenocarcinoma (2005) (0)
Depletion ofBronch us-Associated Lymphoid Tissue Associated with Lung Allograft Rejection (2007) (0)
In reply [13] (2007) (0)
Three-dimensional shape and topology analysis of tissue-cleared tumor samples (2021) (0)
Spontaneous Development Of Murine Pancreatic Intraepithelial Neoplasia (mpanin) In Ela-creert2; Lsl-kras: Insights Into Cellular Origins Of Pancreatic Cancerg12d: Insights Into Cellular Origins Of Pancreatic Cancer Mice: Insights Into Cellular Origins Of Pancreatic Cancer (2007) (0)
Mo1158 The Epidemiology and Clinical Outcome of Pancreatic Solid Pseudopapillary Neoplasms: A Systematic Review (2013) (0)
Loop Electrocautery Excisions of the Cervix/Cone Biopsy (1996) (0)
Abstract LB357: CRISPR-Cas9 targeting of somatic mutations selectively kills cancer cells (2023) (0)
Identification of osteopontin as a serum marker of ampullary carcinoma by gene expression profiling (2003) (0)
Long-term outcome in patients with a pathological complete response after neoadjuvant chemoradiation for pancreatic cancer (2016) (0)
Abstract 4173:In vivo and in vitro propagation of Intraductal Papillay Mucinous Neoplasms (2010) (0)
Case report 769 (2004) (0)
Obesity-related cardiomyopathy - A distinct entity (1993) (0)
Front & Back Matter (2013) (0)
Fetal Membrane Insertion/Single and Twin Placentas (1996) (0)
S2014 Age and Multifocality of Cystic Lesions Are Associated with Increased Risk of Carcinoma in Situ or Invasive Pancreatic Adenocarcinoma in Patients with High Risk Family History (2009) (0)
2040 Continuous infusion (Cl) 5-FU and leucovorin (LCV) combined with hepatic (H), nodal (N), and tumor bed (TB) irradiation (XRT) following panceaticoduodenectomy (PDD) for head of pancreas (HOP) and other periampullary (PA) adenocarcinoma (1996) (0)
Total pancreatectomy: Pathology, complications and outcome (2006) (0)
Relative mRNA expression of pancreas development transcription factors by CD133+ cells isolated after 4 days of exocrine tissue culture. (2015) (0)
Cystic lesions of the pancreas: Why we get it wrong (2016) (0)
Cystic peripancreatic lymphoma (1996) (0)
Intraparenchymal metastases as a cause for local recurrence of pancreatic cancer (2022) (0)
Functional CDKN 2 A assay identifies frequent deleterious alleles misclassified as variants 1 of uncertain significance 2 3 (0)
Intensified adjuvant therapy for periampullary (pancreatic, nonpancreatic) adenocarcinoma using irradiation, 5FU, mitomycin C, leucovorin and dipyridamole (J9625)-update results (2000) (0)
Precancerous neoplastic cells can move through the pancreatic ductal system (2018) (0)
A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. (2022) (0)
ASO Visual Abstract: Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer (2021) (0)
Comprehensive DNA methylation analysis indicates that pancreatic intraepithelial neoplasia lesions are acinar-derived and epigenetically primed for carcinogenesis. (2023) (0)
A primer on artificial intelligence in pancreatic imaging. (2023) (0)
Clinicopathologic Review of Resected Pancreatic Adenosquamous Carcinoma: Importance of Adjuvant Chemotherapy and Radiation (2007) (0)
Complex Specimens/Radical Neck Dissection (1996) (0)
Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood (2019) (0)
Abstract PR007: Three-dimensional genomic analysis of human pancreatic intraepithelial neoplasia (PanIN) reveals striking multifocality and genetic heterogeneity (2022) (0)
Expression of MUC1, MUC2, MUC5AC and CDX2 in Carcinomas of the Gallbladder and Extrahepatic Duct Neuropathology A Clinicopathological Review with Immunohistochemical in the Internal Granular Cell Layer of the Cerebellum in Progressive Multifocal Leukoencephalopathy in 3 Patients with AIDS (2007) (0)
Whole Genome AmplificationとLaser Capture Microdissectionによる家族性膵癌の染色体異常の解析 (2006) (0)
Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models (2020) (0)
Prognostic factors for achieving resection following neoadjuvant radiation therapy for borderline resectable pancreatic adenocarcinoma. (2013) (0)
Tolerance of rat cardiac allografts does not require donor-type "passenger" antigen presenting cells. (1999) (0)
Tissue Factor Expression, Angiogenesis, andThrombosis in Pancreatic Cancer (2007) (0)
Abstract A60: Integrated proteogenomic characterization of pancreatic ductal adenocarcinoma (2019) (0)
Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
Pathologic Outcomes in Borderline Resectable and Locally Advanced Pancreatic Cancer Patients Receiving Neoadjuvant Stereotactic Body Radiation Therapy (2015) (0)
Pancreatic Nerve Sheath Tumors: A Single Institution's Experience (2016) (0)
Volumetric label-free histopathology using optical diffraction tomography (2021) (0)
CYCLOSPORIN A (CSA) AND COMPLEMENT MEDIATE VASCULAR AND PLATELET ACTIVATION IN ALLOGRAFTS.: Abstract# 350 Poster Board #‐Session: P197‐I (2000) (0)
Common Prosthetic Cardiac Valves/Wedge Resection (of Lung) (1996) (0)
Dosimetric Correlations with Toxicity in the First Experience Validating Adjuvant Fractionated Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer (2015) (0)
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression (2023) (0)
Salpingo-oophorectomy for an Ovarian Mass/Incidental Salpingo-ophorectomy (1996) (0)
S2012 Prevalence of High Grade Neoplasia (HGN) in Familial Pancreatic Cancer (PC) Precursors:a Case-Control Study (2009) (0)
Epithelial and mesenchymal circulating tumor cells as markers of survival and recurrence in pancreatic adenocarcinoma (2015) (0)

This paper list is powered by the following services:

Other Resources About Ralph H. Hruban

en.wikipedia.org

What Schools Are Affiliated With Ralph H. Hruban?

Ralph H. Hruban is affiliated with the following schools:

Ralph H. Hruban's Academic­Influence.com Rankings